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 ABSTRACT 
Rong Zhao 
 
ADF/COFILIN ACTIVATION REGULATES ACTIN POLYMERIZATION AND 
TENSION DEVELOPMENT IN CANINE TRACHEAL SMOOTH MUSCLE 
The contractile activation of airway smooth muscle tissues stimulates 
actin polymerization and the inhibition of actin polymerization inhibits tension 
development. Actin depolymerizing factor (ADF) and cofilin are members of a 
family of actin–binding proteins that mediate the severing of F–actin when 
activated by dephosphorylation at serine 3. The role of ADF/cofilin activation in 
the regulation of actin dynamics and tension development during the contractile 
activation of airway smooth was evaluated in intact canine tracheal smooth 
muscle tissues. Two–dimensional gel electrophoresis revealed that ADF and 
cofilin exist in similar proportions in the muscle tissues and that approximately 
40% of the total ADF/cofilin in unstimulated tissues is phosphorylated 
(inactivated). Phospho–ADF/cofilin decreased concurrently with tension 
development in response to stimulation with acetylcholine (ACh) or potassium 
depolarization indicating the activation of ADF/cofilin. Expression of an inactive 
phospho–cofilin mimetic (cofilin S3E), but not WT cofilin in the smooth muscle 
tissues inhibited endogenous ADF/cofilin dephosphorylation and ACh–induced 
actin polymerization. Expression of cofilin S3E in the tissues depressed tension 
development in response to ACh, but it did not affect myosin light chain 
phosphorylation. The ACh–induced dephosphorylation of ADF/cofilin required the 
 vi
Ca2+–dependent activation of calcineurin (PP2B). Expression of Slingshot (SSH) 
inactive phosphatase (C393S) decreased force development and cofilin 
dephosphorylation. Activation of ADF/cofilin was also required for the relaxation of 
tracheal muscle tissues induced by forskolin and isoproterenol. Cofilin activation 
in response to forskolin was not Ca2+–dependent and was not inhibited by 
calcineurin inhibitors, suggesting it was regulated by a different mechanism. 
Cofilin activation is required for actin dynamics and tension development in 
response to the contractile stimulation of tracheal smooth muscle and is regulated 
by both contractile and relaxing stimuli. These concepts are critical to 
understanding the mechanisms of smooth muscle contraction and relaxation, 
which may provide novel targets for therapeutic intervention in the treatment of 
abnormal airway responsiveness. 
 
Susan J. Gunst, Ph. D., Chair 
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CHAPTER I 
Introduction 
 
Asthma is defined in the Global Initiative for Asthma guidelines as a 
chronic inflammatory disorder characterized by reversible airways obstruction 
and airway hyperresponsiveness (21). The burden from asthma in the United 
States has increased by 74% over the past 2 decades (109). In 2005, an 
estimated 7.7% of people (22.2 million) currently had asthma. Rates decreased 
with age; 8.9% of children (6.5 million) had asthma compared to 7.2% of adults 
(15.7 million). Therefore, to study the mechanisms of asthma for the 
development of therapy is important, both medically and economically. 
Airway hyperresponsiveness is defined as exaggerated airway 
narrowing due to nonspecific irritants or pharmacological agonists, which is 
reversible by bronchodilators that relax airway smooth muscles implying that 
airway smooth muscle is the cause (203). Historically, inflammation has been 
regarded as the causal pathophysiological mechanism underlying airway 
hyperresponsiveness, but recent studies demonstrated dissociation between 
airway hyperresponsiveness and airway inflammation (9). Anti–inflammatory 
therapy does not ‘‘cure’’ asthma, and airway hyperresponsiveness can persist in 
asthmatics even in the absence of airway inflammation, suggesting that airway 
hyperresponsiveness may be the fundamental cause of asthma (9). Airway 
smooth muscle cells are thought to be the major effector cells of airway 
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narrowing, although swelling of airway wall compartments and mucus plugging 
may amplify the narrowing (26; 48).  
Studies using isolated bronchial rings and cultures of isolated airway 
smooth muscle cells have shown airway smooth muscle from asthmatics can 
generate more force and, therefore, contract to a greater extent, or to have 
increased maximum shortening velocity and capacity (87; 105). Remodeling the 
cytoskeleton to facilitate the transmission or maintenance of force developed by 
actomyosin interactions (9)  and reorganization of actin filament network (67; 114) 
may be implicated in asthma.  
Although the mechanism of force development from actomyosin 
interaction is well established, the mechanisms underlying actin dynamics in 
smooth muscle are not clear. Studies on cultured cell lines have demonstrated 
that members of a family of “actin–dynamizing proteins”, actin depolymerization 
factor and cofilin (ADF/cofilin), medicate actin dynamics that are required for cell 
motility (14; 15; 28; 29; 35; 45). My thesis work focused on the role of ADF/cofilin 
in regulating actin dynamics and smooth muscle contractility. 
 
I. Basic concepts of smooth muscle contraction 
1. The ultrastructure of smooth muscle and the crossbridge mechanism for 
tension development  
In the past several decades, growing evidence regarding the structure 
and regulation of the contractile apparatus of smooth muscle has accumulated. 
The studies on the molecular organization of the cytoskeleton and contractile 
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apparatus of smooth muscle have shed light on the mechanisms for the plastic 
properties of smooth muscle.  
 
(1) The plastic properties of airway smooth muscle 
Airway smooth muscle tissues are subjected to large changes in shape 
and volume during breathing under physiologic conditions in vivo. A great 
amount of data obtained from both in vivo and in vitro studies has established 
that the mechanical forces are important during breathing in the regulation of 
normal airway responsiveness. The airways are dilated by periodic deep 
inspirations and their responsiveness is reduced by bronchoconstrictors, and 
tidal breathing is necessary to maintain a normal low level of airway reactivity (90; 
154; 156; 188). The isolated airway smooth muscle tissues have similar 
properties: mechanical oscillation or stretch reduces their stiffness and decrease 
responsiveness to contractile stimuli (52; 63; 69; 72; 155; 184). Thus, the effects 
of breathing maneuvers on airway responsiveness in vivo are likely to result from 
the intrinsic properties of the airway smooth muscle tissue itself.  
Airway smooth muscle can rapidly adapt its compliance and contractility 
to accommodate to changes in mechanical forces in the external environment. 
Studies on both airway smooth muscle cells and tissues have established that 
the same contractile stimulus may elicit different responses from the muscle 
depending on its mechanical history–how it has been stretched or shortened 
before receiving the stimulus (64; 67; 68; 72; 73; 184). Furthermore, changes in 
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muscle length or mechanical strain also modulate the mechanical stiffness of the 
smooth muscle tissue. 
 
(2) Ultrastructure of smooth muscle (Figure 1) 
The contractile apparatus in smooth muscle cells includes thin filaments 
and thick filaments. The thin filaments are ~7 nm in diameter, and actin is the 
primary component. The thick filaments are 12–15 nm in diameter, and myosin is 
the primary component. The thick filaments in smooth muscle are assembled in a 
side–polar way, in which all myosin heads have the same polarity along one 
edge of the filament, and the opposite polarity on the other edge (39; 41; 79).  
The side–polar filaments consist of polymerized myosin monomers with the head 
regions extending in opposing directions on each side of the filament. The 
number of the thick filaments is relatively fewer than the thin filaments which 
surround the thick filaments. The ratio of actin to myosin filaments varies in 
different smooth muscle tissues. The lowest ratio is 8:1 in chicken gizzard; the 
middle ratio is approximately 15:1 in vascular muscle; the highest ratio is 50:1 in 
isolated amphibian visceral muscle. Actin is the major constituent of the thin 
filament. Filamentous actin (F–actin) is a polymeric protein composed of 
asymmetric bi–lobed 42 kDa actin monomers (83; 89; 117). Actin filaments form 
the thin filament backbone. Tropomyosin binds along the groove of the actin 
filament. The binding of tropomyosin stabilizes the actin filament (42).  
In smooth muscle tissues, the actin filaments connect with dense 
plaques on the membrane and link to dense bodies in the cytoplasm 
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Figure 1. The ultrastructure of smooth muscle cell. Myofilaments of 
smooth muscle cells contain thick filaments (myosin) and thin filaments (actin). 
Myosin and actin filaments slide against each other to produce contraction of the 
cell. Actin filaments are anchored to the membrane adhesion plaques and the 
dense bodies in the cytoplasm. There are some actin filaments are not 
associated with myosin. 
 
 
 
 
Myosin filament
Actin filament Cytosolic dense body
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(70; 74; 158; 159). The membrane–associated dense bodies, also known as 
“macromolecular adhesion junctions,” form on the intracellular side of the plasma 
membrane at the junctions between F–actin and the extracellular matrix (27; 47; 
157; 198), at which F–actin is connected to integrin proteins via “linker” proteins 
including α–actinin, talin, and filamin. These “linker” proteins can both cross–link 
actin filaments and bind to the β–subunit of integrin heterodimers (40; 140). 
Evidence that the adhesion complexes of smooth muscle are dynamic structures 
has been obtained in studies of airway smooth muscle, vascular smooth muscle 
tissues and in isolated smooth muscle cells using various methods, including 
coimmunoprecipitation, cell fractionation, immunofluorescence analysis, and 
cellular imaging (53; 92; 139; 142; 143; 199-201). 
The molecular structure of the smooth muscle myosin is grossly similar 
to that of skeletal muscle myosin. It is a large asymmetric protein (molecular 
weight (MW) ~520 kDa) made up of six polypeptide chains: two ~205 kDa heavy 
chains that form a dimer, and two pairs of light chains, the 20 kDa “regulatory” 
light chains and the 17 kDa “essential” light chains (3). The myosin heavy chain 
dimer makes up the main body of the molecule, with each heavy chain containing 
a slightly elongated globular head at the amino terminus. The myosin globular 
heads are linked to a long α–helical coiled tail of ~120 kDa which aggregates to 
form the rod–like backbone of the thick filament. Each myosin globular head 
contains the functional motor domains which include the nucleotide and actin–
binding regions. A single essential and regulatory light chain is associated with 
each myosin head. The light chains are localized along the α–helical segment 
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(“neck” region) of the heavy chain at the junction of the globular head and the 
rod–like backbone. 
 
(3) The basic mechanisms of smooth muscle contraction: actomyosin 
crossbridge activation 
Traditionally, smooth muscle contractile regulation has been attributed to 
mechanisms that modulate the number or cycling rate of actomyosin 
crossbridges, either by changing the overlap of actin and myosin filaments or by 
affecting crossbridge activation. Myosin generates force and/or motion by 
mechanical cycles when the myosin head repetitively attaches to actin and 
undergoes a conformational change which results in a power stroke and then 
detaches (189). The energy required for the mechanical power is from the 
enzymatic hydrolysis of adenosine triphosphate (ATP) on the globular myosin 
head. The “lever arm hypothesis”  has been applied to explain the conversion of 
chemical energy into directed movement (145; 146). In this model, the binding of 
ATP to myosin while it is bound to actin results in a series of conformational 
changes in the myosin globular head which reduces its affinity for actin and 
allows it to hydrolyze ATP to adenosine diphosphate (ADP) and inorganic 
phosphate (Pi). As the myosin rebinds to actin and releases the nucleotide, the 
conformational changes are reversed causing movement of the myosin relative 
to actin. The light–chain binding domain (“the neck region”) pivots about a 
fulcrum near where the globular head and light chain binding domains connects 
to each other, resulting in the displacement of actin relative to myosin (61).  
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(4) The limitation of actomyosin crossbridge activation in smooth muscle 
contraction 
The actomyosin crossbridge interaction and associated regulatory 
processes can explain tension development and active shortening of the smooth 
muscle cell; however, crossbridge interactions fail to account for the ability of the 
smooth muscle cell to accommodate cell mechanical responses to the physical 
environment, either while activated or quiescent. Other molecular interactions 
within the cytoskeleton are likely to be responsible for these plastic properties 
and consequently to be important (65).  
 
2. Smooth muscle contraction stimulates actin polymerization 
independently from contractile apparatus activation  
 
(1) Actin polymerization is documented to occur during smooth muscle 
contraction in various studies with diverse approaches 
There is  growing evidence to document that actin polymerization plays 
an important role in regulating active tension development in smooth muscle (71; 
72). Actin polymerization can be induced by contractile agonists stimulation in 
smooth muscle tissues and  cells in culture (33; 50; 76; 80; 81; 114; 162; 172; 
199; 200; 202).  
An increase in the pool of F–actin and a decrease in the pool of G–actin 
during smooth muscle contraction has been documented in diverse types of 
smooth muscle cells and smooth muscle tissues with different approaches. Since 
 9
the 1990s, the dynamics of actin assembly from G–actin to F–actin have been 
documented in tracheal smooth muscle tissue by several groups with various 
methods, such as DNase I inhibition, cellular fractionation and 
immunofluorescence staining (80; 88; 114; 199). A similar phenomenon has also 
been reported by Barany et al. in arterial and other smooth muscle tissues by 
measuring the exchange rates of actin–bound nucleotides (20). The amount of 
the reduction of the G–actin pool during the contractile stimulation of vascular 
smooth muscle was comparable to that in tracheal smooth muscle. Frequently 
used approaches for the measurement of actin polymerization include cell 
fractionation (147; 174; 199), fluorescence imaging to visualize G– and F–actin in 
isolated smooth muscle cells or smooth muscle tissues with G– and F–actin–
specific stains (33; 50; 81; 88; 176) and electron microscopic studies to quantify 
actin filament density (76). All of these approaches have consistently shown that 
an increase in F–actin and a decrease in G–actin occurs when smooth muscle 
cells or tissues are activated by a contractile stimulus.  
 
(2) Actin dynamics contributes to the plastic properties of smooth muscle 
The observations of actin dynamics in smooth muscle tissues are 
analogous to observations in many non–muscle cells (175), but stand in marked 
contrast to observations in skeletal muscle, where no significant G–actin pool has 
been  detected and the rate of actin–bound nucleotide exchange is extremely low. 
Thus, the dynamic state of the actin cytoskeleton may be a unique feature of 
smooth muscle cells, not common to cells of other muscle tissues types. 
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Compared with skeletal muscle tissues, smooth muscle tissues also contain a 
much higher ratio of F–actin to myosin and maintain a significant pool of F–actin 
that does not interact with myosin filaments (158). The abundance of actin in 
smooth muscle and its highly dynamic state may contribute to the plastic 
properties of smooth muscle, the unique functional characteristics of this tissue.   
 
(3) Actin polymerization is required for smooth muscle force development 
The actin filaments is smooth muscle have been classified into 
“contractile actin” and “cytoskeletal actin”. The evidence from our lab supports a 
hypothesis that the contractile actin filaments localize around the thick filaments, 
forming the contractile apparatus, while  cytoskeletal actin filaments localize at 
the subcortical area and are not structurally associated with myosin (74). The 
dynamic nature of the cytoskeletal actin cytoskeleton in smooth muscle makes it 
more like that of nonmuscle motile cells than sarcomeric actin in striated muscles. 
A corollary of this hypothesis is that many of the same actin–modifying proteins 
and regulatory pathways that control actin dynamics in nonmuscle cells are 
important in smooth muscle contraction (55; 56; 70; 74). (Figure 2) 
Tension development in many smooth muscle tissues is dramatically 
depressed by short term exposure to inhibitors of actin polymerization  (4; 114; 
132; 139; 196), which indicates that the polymerization–depolymerization of actin 
filaments is part of the contraction–relaxation cycle of smooth muscle. The short–
term application of pharmacologic actin polymerization inhibitors, such as 
latrunculin, which works by sequestering actin monomers, and cytochalasin, 
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Figure 2. Hypothesized model for smooth muscle contraction (74). The 
cortical actin around the membrane undergoes polymerization with the contractile 
stimulation. The formation of a subcortical actin filament network strengthens the 
membrane for the transmission of force generated by the actomyosin system. 
Thus the dynamic character of the cortical actin cytoskeleton in smooth muscle is 
similar to that in several nonmuscle motile cells. A main idea of this hypothesis is 
that many of the actin–modifying proteins and regulatory pathways that control 
actin dynamics in nonmuscle cells are important in smooth muscle contraction  
 
 
Contractile
Stimulus
Myosin filamentActin filament Cytosolic dense body
Extracellular Matrix
Membrane
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which works by capping actin filaments (25; 36; 38), have been reported to 
depress tension development in response to contractile stimulation in airway 
smooth muscle (10; 46; 114; 160; 180; 196), vascular smooth muscle (4; 32-34; 
133; 134; 147; 149; 153; 191), uterine smooth muscle (153) and intestinal 
smooth muscle (110; 131). Further evidence regarding the importance of actin 
polymerization in the process of mechanical tension development in smooth 
muscle has been obtained from studies applying molecular constructs or 
peptides to interrupt specific steps in the actin polymerization process. These 
interventions also inhibit tension development in smooth muscle tissues in 
response to contractile stimuli (12; 169; 170; 174; 199; 200). Cellular imaging 
demonstrated that the depression of tension development by inhibiting actin 
polymerization does not result from disruption of the organization or integrity of 
the contractile apparatus (4; 114; 199).  
 
(4) Actin polymerization is independent of myosin light chain (MLC) 
phosphorylation in smooth muscle 
Actin polymerization inhibitors can dramatically reduce tension 
development in airway smooth muscle without significantly affecting MLC 
phosphorylation or myosin ATPase activity,  indicating that actin polymerization 
induced  by contractile stimulation does not regulate the processes involved in 
the activation of contractile protein or crossbridge cycling (4; 114; 199). These 
results suggest that active tension generation in smooth muscle tissues depends 
on two parallel cytoskeletal processes: 1) the activation of contractile proteins 
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leading to crossbridge cycling and the sliding of actin and myosin filaments; 2) the 
polymerization of actin and remodelling of cytoskeleton organization. In the 
absence of either of these events, tension development does not occur.  
In summary, actin polymerization regulates tension development by a 
cellular process that is distinct from and independent of cross–bridge cycling. 
Thus, a new model for smooth muscle contraction has been proposed in which a 
contractile stimulus activates independent, but parallel, signaling pathways that 
regulate the processes of actin polymerization and contractile protein activation, 
both of which are essential to the process of shortening and tension development 
in smooth muscle tissues (74). 
The above studies demonstrate that a relatively small amount of actin 
undergoes polymerization during smooth muscle contraction. It also suggests 
that this labile pool of actin serves a specialized function that is distinct from that 
of the “thin filament” actin that interacts with myosin to regulate cross–bridge 
cycling. However, the nature of the pool of actin that undergoes polymerization 
and its function during the contraction is currently an unresolved question. Much 
of the existing evidence supports a model in which actin polymerization occurs in 
a submembranous area of the smooth muscle cell (74). The formation of a 
network of submembranous actin in smooth muscle cells may function to 
enhance membrane rigidity and to connect the contractile and cytoskeletal 
filament lattice to the membrane to transmit the tension generated by cross–
bridge cycling (66; 74; 198; 199). Submembranous actin polymerization may also 
enable the cell to adapt its shape and stiffness and contractility to external and 
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internal mechanical forces imposed on it, and it may occur in regions within 
smooth muscle cells in which the membrane tension is greatest (74). 
 
II. Molecular Mechanisms for Actin Polymerization.  
In the previous section (section I.2.), evidence was presented that actin 
polymerization and the dynamic remodeling of the actin cytoskeleton play critical 
roles in the regulation of contractility and the physiologic properties of airway 
smooth muscle, as well as in other smooth muscle tissues. However, the 
mechanisms of actin polymerization in smooth muscle cells are still not 
established.  
 
1. The general mechanism of actin polymerization  
The ability of a cell to coordinate the assembly and disassembly of its 
actin cytoskeleton is essential for cell integrity, motility, membrane trafficking and 
shape changes (116). Many of the mechanisms regulating actin filament 
assembly and dynamics are derived largely from studies in reconstituted in vitro 
systems, and from the evaluation of mechanisms of cell locomotion and motility 
via pseudopods in unicellular organisms, immune cells, migrating fibroblasts, and 
growth cones (144). Actin filaments are polarized in vitro and in vivo.  G–actin 
adds preferentially to the fast–growing (barbed) end of the F–actin and this is the 
major site of F–actin elongation in vivo. The slower growing ends are called 
pointed ends. G–actin binds to and hydrolyzes one molecule of ATP, which 
provides the energy to maintain the difference in affinity for G–actin addition 
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between the barbed and pointed ends. The addition of ATP–G–actin is favored at 
the barbed end of the F–actin, while ADP–G–actin is lost from the pointed end. 
This, together with the fact that barbed ends are oriented towards the plasma 
membrane in a cell, allows the barbed end to undergo rapid growth that drives 
protrusion of the cell membrane and thus cell motility (116). 
Actin is the most abundant protein in many eukaryotic cells, with 
concentrations of over 100 μM in some cell types. Pure actin requires a critical 
concentration of only 0.1–1 μM for polymerization at the barbed end, so the cell 
has evolved mechanisms to control the number of free barbed ends. Currently 
there are three presumed mechanisms for the free barbed end generation, and 
thus, the regulation of actin filament assembly, in cells (77; 116; 144). 
First, cells regulate the growth of F–actin via capping proteins such as 
gelsolin and cap Z, which bind to the barbed ends of F–actin and prevent further 
elongation. Gelsolin and cap Z together are able to cap the majority of barbed 
ends within most animal–cell types. Caps can be removed when signals trigger 
actin assembly, leading to rapid F–actin elongation (116). 
Second, F–actin severing by ADF (actin–depolymerizing factor)/cofilin 
provides a source of free barbed ends. A detailed description of the activity of 
ADF/cofilin is in section II.2,  
Finally, de novo F–actin nucleation produces new F–actin seeds. 
Forming F–actin from G–actin alone requires the initial association of G–actin 
molecules to form dimers and trimers. Kinetic modeling has demonstrated that 
the initial formation of dimers and trimers is energetically unfavorable (78; 111). 
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This leads to the nucleation of F–actin from G–actin alone. It is now accepted 
that nucleators, such as the Arp2/3 complex, formins, and spire proteins, 
together with uncapping and severing proteins, nucleate actin networks in 
response to environmental cues (60; 111; 122; 144; 163). 
 
2.  Actin Depolymerizing Protein (ADF)/Cofilin is required for Actin 
polymerization  
(1) Basic function of ADF/cofilin 
ADF/Cofilin family is named as “actin depolymerizing factor” because it 
was first discovered in chicken and porcine brain based on its capacity to form 
“cofilamentous” structures with actin filaments and to depolymerize the actin 
filaments (16; 127).  
 
(2) Isoforms of ADF/cofilin family 
The ADF/cofilin family is ubiquitously present in the eukaryocytes (15; 
101). The molecular weight is around 19–kDa. This small protein has a single 
domain, termed as ADF–homology domain (101). In mammalian systems, the 
ADF/cofilin family includes of three highly conserved isoforms: cofilin 1 (non–
muscle cofilin) (127), cofilin 2 (muscle cofilin) (1) and ADF (actin depolymerizing 
factor or destrin) (121). Studies on mouse have demonstrated the various 
expression levels of the three isoforms in different cells or tissues (75; 183). 
Cofilin 1 is the predominant isoform and is expressed ubiquitously in most adult 
tissues. ADF is post–natally upregulated primarily in epithelial and endothelial 
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tissues and the amount is usually lower than cofilin 1. Cofilin 2 replaces cofilin 1 
in striated muscle and is the unique isoform expressed in differentiated skeletal 
muscle and the major isoform in cardiac muscle at the later stages of 
embryogenesis (125). Cofilin 2 is expressed in low level in other adult cells or 
tissues, including smooth muscle.  
Studies of the isoforms of ADF/cofilin suggest that different isoforms of 
ADF/cofilin play qualitatively similar roles in regulating actin dynamics, but the 
effects on actin dynamics are quantitatively different during different 
developmental processes (22; 23; 37; 43; 103; 127; 138; 182). Lappalainen and 
colleagues reported that ADF and cofilin 1 play overlapping roles in F–actin 
depolymerization in mouse NIH 3T3, B16F1, and Neuro 2A cells by knockdown 
with siRNA. However, studies on the role of ADF/cofilin during development of 
knockout mouse showed that  cofilin 1 is critical for fetal survival (75), while ADF 
is more important for development after birth. 
 
(3) The basic functions of ADF/cofilin 
The studies in vitro demonstrate that the effects of ADF/cofilin on actin 
dynamics are multiple and complex. ADF/cofilin prefers to bind to ADP–actin 
subunits that are produced following ATP hydrolysis and the release of inorganic 
phosphate within the F–actin filament (15; 19; 107). ADF/cofilin inhibit nucleotide 
exchange on ADP–G–actin (15; 127). Direct observation of actin filaments by 
electron microscopy has shown that each cofilin contains two actin binding sites, 
which bind in the cleft between the two actin monomers in an actin filament and 
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weaken the lateral interactions of the F–actin (11; 24). Cofilin binding to F–actin 
induces a conformational twist in the actin filament structure that propagates over 
a long range from the actual cofilin–binding site and this is suggested to underlie 
their fragmenting/severing activity (54; 112; 185). ADF/cofilin accelerates 
spontaneous polymerization of G–actin and increases the rate of actin subunits 
dissociation from the pointed end (29; 30). 
 
(4) Dephosphorylated ADF/cofilin is the active form 
Phosphorylation and dephosphorylation of its NH2–terminal Ser–3 is the 
critical way to regulate ADF/cofilin activity. Phosphorylation at Serine 3 abolishes 
the binding ability of ADF/cofilin to F–actin and thus inhibits its severing function 
(Figure 3) (5; 15; 18; 113; 120) and thus dephosphorylation cause reactivation of 
ADF/cofilin. 
 
(5) The mechanisms of ADF/cofilin on actin dynamics 
ADF/cofilin crucially contributes to actin dynamics, but how exactly 
ADF/cofilin regulates actin polymerization and cell motility is still under dispute. 
Evidence from a number of studies of different cell types (neuroblastoma, 
fibroblast, melanoma, mammary adenocarcinoma, glioblastoma–astrocytoma 
cells, T lymphoma (Jurkat) and carcinomas from the cervix epithelia (HeLa), 
colon (KM12), hepatocytes (HepG2), and kidney fibroblasts (COS1) in vitro and 
in vivo have demonstrated that the dephosphorylation and activation of 
ADF/cofilin is required for cell motility (6; 57; 62; 84; 126; 186; 192; 194; 195). 
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Figure 3. The molecular structure of ADF/cofilin. ADF/cofilin is a 
small protein. The serine 3 at the NH2–terminal is the critical site to regulate its 
activation. Phosphorylation of the NH2–terminal ser–3 on ADF/cofilin abolishes 
its ability to bind actin and thus its severing function is inhibited. 
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There are also some studies demonstrating that phosphorylation and inactivation 
of ADF/cofilin are necessary for motility to occur (13; 128).  
The above debate results in two models of ADF/cofilin function: (1). 
ADF/cofilin severs the actin filaments; (2). ADF/cofilin increases the off–rate of 
actin subunits from the pointed end. Filament severing and off–rate enhancement 
not only increases turnover but can also lead to nucleated filament growth from 
new filament ends. Thus, whether ADF/cofilin causes filament growth or 
shrinkage will depend on the availability of actin subunits within the region of the 
cell where this process occurs (35). Studies of actin dynamics in vitro and in cells 
have shown that actin polymerization is regulated by proteins that control the 
availability of a G–actin pool for incorporation into actin filaments, and the 
availability of free “barbed” or “plus” ends of F–actin which can undergo 
polymerization (30; 98). The family of ADF/cofilin proteins participates in both of 
these processes. Thus these proteins are termed “actin–dynamizing” proteins 
due to their critical role in regulating the actin dynamics which enables the rapid 
turnover of the actin cytoskeleton (17; 28; 35).  
ADF/cofilin creates free barbed ends via a severing activity that is 
essential in cell spreading and lamellipodia formation in response to epidermal 
growth factor (EGF) (31; 86; 116) and other signals. ADF/cofilin can increase the 
rate of depolymerization at the pointed end of the actin filament (31; 107; 167). In 
reconstituted in vitro systems, ADF/cofilin acts alone or synergistically with 
profilin to regulate the availability of free barbed ends of actin filaments for 
polymerization (35; 44; 93), with ADF/cofilin presumably increasing the 
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availability of barbed ends for polymerization and profilin increasing the 
availability of G–actin. 
The important role of ADF/cofilin in cell mobility is well established (17; 
28; 35). ADF/cofilin is an essential for both the actin polymerization and 
depolymerization processes during cell movement: It binds to actin filaments and 
severs them, thereby promoting actin disassembly and the formation of new 
barbed ends, which enables the nucleation of new actin filaments by the Arp2/3 
complex. Arp2/3 complex is a cellular initiator of actin filament nucleation, (78; 
106; 123). During cell migration, on one hand, new F–actin is assembled at the 
leading edge of the cell; on the other hand, F–actin at the rear of the actin 
network is disassembled (35). ADF/cofilin also contributes to F–actin assembly 
by replenishing the G–actin pool required for polymerization (Figure 4) (17; 28; 
93; 131). 
There have been very few studies of the role of ADF/cofilin in smooth 
muscle physiological functions. One study from Brophy and colleagues 
demonstrated ADF/cofilin is activated (dephosphorylated) in response to forskolin 
and isoproterenol in cultured human airway smooth muscle cells (95). Another 
study from Hellstrand and colleagues has shown that stretch induced actin 
polymerization and increased cofilin expression in vascular smooth muscle 
tissues (7). However, there is virtually no information about the role of ADF/cofilin 
in regulating smooth muscle contraction. 
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Figure 4. The role of ADF/cofilin in actin dynamics. Severing by 
ADF/cofilin has two possible consequences: in the presence of G–actin, severing 
causes nucleation of polymerization (left); in the absence of G–actin, severing 
causes net depolymerization (right).  
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3. Signaling pathways regulating ADF/cofilin phosphorylation (inactivation) 
and dephosphorylation (activation)  
Phosphorylation (inactivation) of ADF/cofilin at Serine 3 is mediated by 
LIM  kinases (LIMK) (151) and testicular protein kinases (TESK) (178). Both 
LIMK and TESK have two isoforms: LIMK1/2 (2; 51; 113) and TESK1/2 (113; 
178).The dephosphorylation (activation) of ADF/cofilin is mediated by the 
ADF/cofilin–specific phosphatases slingshot (SSH) and chronophin (85) and 
other nonspecific phosphatases, including protein phosphatase 1 (PP1), protein 
phosphatase 2A (PP2A) and protein phosphatase 2B (PP2B or calcineurin) (18; 
113). (Figure 5) 
 
 (1) Phosphorylation (inactivation) of ADF/cofilin by LIMK 
Current evidence suggests that the signaling pathways that regulate 
ADF/cofilin phosphorylation are complex. ADF/cofilin is the substrate of LIM 
Kinase (LIMK) (119; 135; 136; 151), which can be activated through Rho–family 
GTPases via the activation of Rho kinase (ROCK) (8; 108; 151; 164; 165; 193), 
or via Cdc42/Rac–mediated activation of PAK1, 2 or 4 (13; 49; 108; 118; 128; 
151; 166). Studies performed in neuroblast, kidney fibroblast, and human cervical 
cancer cells  indicate that ADF/cofilin phosphorylation is inhibited by the inhibition 
of ROCK with the ROCK–specific inhibitor, Y27632 (7; 108; 164; 165). Studies in 
vitro using mutant plasmids in neuroblastoma cells and T lymphocytes encoding 
inactive mutants of Rac have also documented a Cdc42/Rac–PAK pathway for 
the regulation of LIMK activation and ADF/cofilin phosphorylation (108; 128). In 
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Figure 5. Signaling pathways that regulate ADF/cofilin activation 
and inactivation. ADF/cofilin can be phosphorylated (inactivated) at Serine 3 by 
LIM kinases (LIMK) and testicular protein kinases (TESK). It can also be 
dephosphorylated (activated) by the ADF/cofilin–specific phosphatases slingshot 
(SSH) and chronophin and other nonspecific phosphatases, including protein 
phosphatase 1 (PP1), protein phosphatase 2A (PP2A) and protein phosphatase 
2B (PP2B or calcineurin). 
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addition, there are pathways that activate LIMK independently of GTPase. One 
example is calcium and integrin binding protein 1 (CIB1)–PKA1–LIMK1 pathway. 
It was reported by Paris and colleagues that activation of LIMK1 through CIB1–
PAK1 with the application of CIB1 overexpression and RNA interference 
increases cofilin phosphorylation and prevent platelets migration (104). The other 
example is integrin–MAPKAPK–LIMK1 pathway. It was reported by Reisler and 
colleagues that activation of LIMK1 through integrin–MAPKAPK in endothelial 
cells (97). 
 
(2) Phosphorylation (inactivation) of ADF/cofilin by TESK 
TESK and LIMK appear to have different extracellular signals for 
ADF/cofilin phosphorylation. Activation of TESK was demonstrated to be 
unrelated to ROCK or PAK activation in cervical carcinoma cells by using the 
ROCK inhibitor (Y27632) and overexpression of Rho, Cdc42, ROCK or PAK in 
HeLa cells and COS7 cells (177).The activation of integrin associated signals, α–
parvin (or actopaxin, a focal adhesion protein), 14–3–3β (a member of scaffold 
protein family that binds phosphoserine/threonine motifs), or sprouty–4 (Spry–4, 
an inhibitor of receptor tyrosine kinase (RTK)–MAP kinase signaling) inhibits 
TESK activity in HeLa cells and COS–7 cells  (100; 179; 181). The interaction 
between actopaxin  or 14–3–3β and TESK1 is inhibited by fibronectin (100; 179).   
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(3). Dephosphorylation (activation) of ADF/cofilin by phosphatases  
The pathways that regulate the phosphatases that dephosphorylate 
ADF/cofilin are not clear. In 1998, several nonspecific phosphatases were 
demonstrated to dephosphorylate ADF/cofilin in rat pheochromocytoma by using 
pharmacological inhibitors (18; 113). In 2002, Uemura and colleagues first 
reported a specific phosphatase for ADF/cofilin, named “Slingshot (SSH)” (130). 
In 2005, Bokoch and colleagues reported another specific phosphatase for 
ADF/cofilin, named as “chronophin” (59). 
In both human and mouse, the Slingshot phosphatases are represented 
by three genes (SSH–1, –2, and –3), each with long and short variants with 
distinct tissue expression patterns. Slingshot seems to be widely expressed in 
various organisms, but is notably absent in Saccharomyces cerevisiae, 
Caenorhabditis elegans and Arabidopsis thaliana. In mammalian cells SSH–1L, 
along with SSH–2L and SSH–3L, dephosphorylates both phospho–ADF and 
phospho–cofilin at the critical Ser3 residue. Notably, SSH–3L was less effective 
in dephosphorylating these substrates in comparison with the two other isoforms 
(85; 137). 
Ca2+ ionophore A23187, Ca2+ –mobilizing agonists, such as ATP and 
histamine, and Ca2+ –calcineurin (PP2B) induced SSH–1L activation, correlating 
with cofilin dephosphorylation in HeLa cells (187). Dephosphorylation of 
Slingshot by λ–phosphatase increased its phosphatase activity, but Slingshot 
activity was inhibited by PAK4–mediated phosphorylation in rat hippocampal 
neurons (161). The PtdIns 3–kinase (PI3K) inhibitor wortmannin has been shown 
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to antagonize cofilin dephosphorylation induced by fMLP (Formyl–Methionyl–
Leucyl–Phenylalanine), a chemotaxis, or tissue plasminogen activator (TPA) in 
polymorphonuclear leukocytes (15). Mizuno and colleagues (129) reported that 
insulin–dependent actin reorganization occurs through PI3K and SSH, since 
insulin stimulated human breast adenocarcinoma cells exhibit SSH activation and 
cofilin dephosphorylation that is abolished by PI3K inhibition (124). 
In 2008, Brophy and colleagues demonstrated cofilin is activated 
(dephosphorylated) in response to forskolin and isoproterenol in cultured human 
airway smooth muscle cells, suggesting a possible role of ADF/cofilin in 
regulating actin dynamics during the smooth muscle relaxation (95). 
There are some studies in human breast adenocarcinoma, monkey 
kidney fibroblasts, human embryonic kidney cells and Xenopus cycling extracts 
demonstrating that the small GTPases  Rac and Rho dephosphorylate cofilin 
(124; 168), which suggests that small GTPase  family members may regulate 
SSH activity. Jones and colleagues proposed a novel mechanism in which α6β4 
integrin activates cofilin via Rac1, 14–3–3 proteins, and SSH regulates cofilin 
activation in human epidermal keratinocytes (94). 
Signal transduction pathways for chronophin activation are poorly 
characterized. Chronophin phosphatase activity is insensitive to classical 
thiol−based serine/threonine phosphatase inhibitors, which were reported for 
physiological ADF/cofilin phosphatase activity (15; 197). Chronophin exhibits 
several predicted interaction motifs regulated by both PI3K and PLCγ, both of 
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which were suggested to be involved in signaling to ADF/cofilin 
dephosphorylation in polymorphonuclear leukocytes  (15).  
There is also a study of the interaction between LIMK and SSH. 
Bernaard and colleagues proposed a reciprocal control of LIMK1 and SSH1L 
activity, and that SSH1L can directly dephosphorylate and regulate LIMK1 
activity in mouse embryo fibroblasts (161).  
In summary, the signalling pathways that regulate ADF/cofilin activation 
(dephosphorylation) and inactivation (phosphorylation) are complex and not 
established. There is currently almost no information on the mechanisms by 
which stimuli regulate ADF/cofilin phosphorylation during force development in 
smooth muscle tissues.   
In conclusion, there is growing evidence that actin polymerization and 
dynamic remodeling of the actin cytoskeleton are important in the regulation of 
the physiologic properties of smooth muscle. The overall thesis work is based on 
the hypothesis that ADF/cofilin might play an important role in the regulation of 
actin dynamics in smooth muscle tension development. In Chapter II, the roles of 
ADF/cofilin in regulating actin polymerization in smooth muscle in response to 
contractile and relaxing stimuli are determined. The signal pathways that activate 
ADF/cofilin are evaluated. 
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 CHAPTER II 
Results 
II.i. 
Activation of ADF/cofilin is required for 
actin polymerization and contraction in canine tracheal smooth muscle 
 
1. Summary 
Recent studies have documented that the cytoskeletal organization of 
differentiated smooth muscle cells and tissues is dynamic, and it is regulated 
during contractile stimulation (66; 74; 198). Dynamic changes in cytoskeletal 
organization may enable smooth muscle cells to modulate their structure and 
contractility in response to changes in their external environment (71; 198). Actin 
polymerization can be triggered by contractile stimuli in many smooth muscle 
tissues, and tension development can be dramatically depressed by short term 
exposure to inhibitors of actin polymerization (10; 33; 74; 80; 88; 91; 114; 169; 
173; 199). In airway smooth muscle, the inhibition of actin polymerization can 
inhibit tension development in the absence of an effect on myosin light chain 
phosphorylation, suggesting that actin polymerization regulates tension 
development by processes independently of cross–bridge cycling (74; 114; 173; 
199).  
ADF/cofilin play a critical role in the rapid adaptation of the actin 
cytoskeleton to localized cellular functions (17; 28; 35). The activation of 
ADF/cofilin is essential for cell motility and polarized cell migration, but the role of 
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ADF/cofilin on the regulation of actin dynamic and contraction in smooth muscle 
tissue is not known. I hypothesized that ADF/cofilin might play an important role 
in the regulation of actin dynamics in smooth muscle during contractile activation. 
In the present study, an inactive cofilin phosphomimetic (cofilin S3E), which has 
minimal actin severing activity (113) (Figure 6), was expressed in the airway 
smooth muscle tissues. Our results demonstrate that ADF/cofilin undergoes 
dephosphorylation in response to contractile stimulation in smooth muscle 
tissues and that ADF/cofilin dephosphorylation is necessary for both actin 
polymerization and active tension generation. The results demonstrate that the 
activation of ADF/cofilin is a necessary step for the dynamic reorganization of 
actin that occurs during the contraction of smooth muscle tissues.  
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Figure 6. The structure of cofilin wild type and inactive cofilin mutant. 
The inactive cofilin mutant (cofilin S3E), a phospho–cofilin mimetic, is 
constitutively inactive, so it has no severing ability. Inactive cofilin mutant (cofilin 
S3E) may sequester the cofilin phosphatase, thereby preventing the activation of 
the endogenous cofilin.  
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2．Results 
2.1. Contractile stimulation of tracheal smooth muscle tissues induces 
ADF/cofilin dephosphorylation on Ser–3 (Figure 7). First we measured if the 
ADF/cofilin phosphorylation changes with contractile stimulation using 
acetylcholine (ACh) or KCl at different time points. Canine tracheal smooth 
muscle strips were maintained for 30 min without contractile stimulation and then 
contracted isometrically with 10–5 M ACh for 15 or 30 s or 1, 5, or 15 min or left 
unstimulated. ADF/cofilin phosphorylation on Ser–3 was elevated in unstimulated 
tissues and decreased significantly in response to ACh stimulation. The decrease 
in ADF/cofilin phosphorylation was evident 15 s (0.25 min) after stimulation with 
ACh and persisted for the duration of the contraction (Figure 7A and 7B). 
Differences in ADF/cofilin phosphorylation in ACh–stimulated and unstimulated 
tissues were statistically significant at all time points (n = 6, p < 0.05). The time 
course of the decrease in ADF/cofilin phosphorylation was similar to the time 
course of the increase in force development in response to ACh stimulation. 
ADF/cofilin phosphorylation 30 or 60 min after stimulation with ACh was not 
significantly different from ADF/cofilin phosphorylation at 15 min, suggesting that 
the activation of ADF/cofilin was sustained for the duration of the contraction 
(data not shown).  
To determine whether the decline in ADF/cofilin phosphorylation during 
contractile stimulation was dependent on a receptor–mediated mechanism, 
muscles were stimulated with 60 mM KCl, and ADF/cofilin phosphorylation was 
analyzed 15 and 30 min after stimulation. ADF/cofilin phosphorylation decreased 
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Figure 7. ADF/cofilin phosphorylation decreases during contractile 
stimulation with ACh or KCl in smooth muscle tissues. A and C. 
immunoblots of phospho–ADF/cofilin (P–ADF/cofilin) and cofilin in six muscle 
tissues stimulated with ACh for the indicated time periods (0.25, 0.5, 1, 5, and 15 
min) or unstimulated (US), and three muscle tissues stimulated with KCl for 15 or 
30 min or unstimulated. ADF/cofilin phosphorylation and total cofilin were 
quantitated simultaneously using a LI–COR Odyssey infrared scanner. B. Mean 
ratios of P–ADF/cofilin/cofilin and active tension (% of maximum) at increasing 
time intervals during contractile stimulation with ACh. * Significant difference in 
P–ADF/cofilin/cofilin between unstimulated muscles (US) and muscles stimulated 
with ACh (p < 0.05). All values are means ± S.E. (n = 6). 
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 significantly to 61 ± 5% (n = 6, p < 0.05) in response to KCl stimulation, and the 
decrease in ADF/cofilin phosphorylation persisted for the 30 min duration of the 
contraction. The decrease in ADF/cofilin phosphorylation was less than during 
ACh stimulation, but force development in response to KCl stimulation was only 
about 60% of that observed with ACh stimulation. The results demonstrate that 
both receptor–mediated agonists and depolarization with KCl stimulate the 
dephosphorylation of ADF/cofilin and its activation in tracheal smooth muscle 
tissues. 
 
2.2. ACh stimulation induces similar dephosphorylation at Ser–3 of ADF 
and cofilin in tracheal smooth muscle tissues (Figure 8). Two–dimensional 
gel electrophoresis was used to determine which isoforms of ADF/cofilin are 
present in tracheal smooth muscle and to quantitate the effects of stimulation 
with ACh on their phosphorylation (Figure 8A). We found that cofilin and ADF 
were represented in similar proportions (54 ± 2 and 46 ± 2%, respectively) (n = 4). 
Cofilin2 represented less than 7% of the total ADF/cofilin detected in the muscle 
tissue. In the unstimulated smooth muscle tissues, the phospho–cofilin was 40 ± 
3% of total cofilin, and this proportion decreased to 14 ± 3% with ACh stimulation 
(Figure 8B) (n = 4). The proportion of phospho–ADF in unstimulated smooth 
muscle was 38 ± 4%, and this decreased to 14 ± 1% with ACh stimulation. 
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Figure 8. Phosphorylation of both cofilin and ADF decreases with 
ACh stimulation of smooth muscle tissues. Immunoblots ADF and cofilin 
isoforms obtained on extracts of stimulated and unstimulated muscles after 
separation of proteins by two–dimensional electrophoresis. A. representative 
immunoblot from extracts of one unstimulated (US) smooth muscle tissue, and 
one stimulated smooth muscle tissue (ACh), probed with anti–ADF/cofilin 
antibody (left) and stripped and reprobed with anti–cofilin antibody (right). B. 
mean values of the proportions of P–cofilin/total cofilin and P–ADF/total ADF in 
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the muscle extracts. All values are means±S.E. * significantly different from 
unstimulated group, p < 0.05 (n = 4). 
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2.3. Expression of the inactive cofilin S3E mutant inhibits the 
dephosphorylation of endogenous ADF/Cofilin induced by ACh (Figure 9).  
Plasmids encoding wild type cofilin (cofilin WT) or the inactive phosphomimetic 
cofilin mutant S3E (cofilin S3E) were introduced into smooth muscle strips by 
reversible permeabilization. Transfected tissues and control untreated tissues 
were then maintained in an incubator for 2 days to allow for the expression of 
recombinant proteins. Muscle tissues were stimulated with 10–5 M ACh for 5 min 
or left unstimulated and then frozen for the analysis of ADF/cofilin 
phosphorylation on Ser–3. 
The amount of total cofilin was 70–80% higher in each group of muscle 
strips treated with cofilin WT or cofilin S3E compared with tissues without 
plasmid treatment (n = 5 or 6, p < 0.05), consistent with a robust expression of 
the recombinant proteins in the transfected tissues (Figure 9C). There were no 
significant differences in the amount of cofilin in tissues expressing wild type or 
mutant cofilin constructs. The amount of P–ADF/cofilin in unstimulated muscle 
tissues treated with either cofilin WT or cofilin S3E was also significantly higher 
than in control tissues, reflecting the higher levels of cofilin in these tissues. 
When the P–ADF/cofilin values were normalized to total cofilin, the amount of 
phosphorylated ADF/cofilin in the cofilin WT–treated and unstimulated cofilin 
S3E–treated muscles was not significantly different from untreated muscles. 
Stimulation with ACh caused a significant decrease in the amount of P–
ADF/cofilin in untreated and cofilin WT–treated tissues; when normalized either 
to GAPDH or to total cofilin. In contrast, ACh did not cause a significant
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Figure 9. Expression of cofilin S3E inhibits dephosphorylation of 
ADF/cofilin in response to ACh. A. representative immunoblot of extracts from 
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six smooth muscle tissues treated with plasmids encoding wild type cofilin (cofilin 
WT), cofilin S3E, or from tissues not treated with plasmids (No plasmid). 
Immunoblots were probed with antibodies to phospho–ser–3 ADF/cofilin, cofilin, 
and GAPDH. B. mean values for P–ADF/cofilin/GAPDH and P–ADF/cofilin/total 
cofilin in muscle strips expressing wild type cofilin or cofilin S3E and stimulated 
with ACh or unstimulated (US). Values are normalized to the no plasmid 
unstimulated group. All values are means ± S.E. * significantly different from the 
unstimulated group for the same treatment (n = 5–6, p < 0.05). C. mean values 
for cofilin/GAPDH in muscle strips expressing wild type cofilin or cofilin S3E and 
stimulated with ACh or unstimulated (US). Values are normalized to the no 
plasmid unstimulated group. All values are means ± S.E. * significantly different 
from the no plasmid unstimulated group (n = 5–6, p < 0.05). 
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decrease in the amount of phosphorylated ADF/cofilin in muscle tissues treated 
with cofilin S3E, whether normalized to GAPDH or total cofilin. Thus, expression 
of the cofilin S3E mutant in the muscle tissues markedly suppressed ADF/cofilin 
dephosphorylation and activation in response to stimulation with ACh (Figure 9A 
and 9B). 
We used two–dimensional gel electrophoresis to evaluate the effects of 
the expression of cofilin S3E on the phosphorylation of both ADF and cofilin in 
response to ACh stimulation and to quantify the amount of cofilin S3E in the 
smooth muscle tissue (Figure 10A and 10B). Cofilin S3E represented 34 ± 5% of 
the total ADF/cofilin (n = 4). The expression of cofilin S3E caused comparable 
inhibition of the dephosphorylation of both cofilin and ADF in response to ACh.  
 
2.4. Expression of cofilin S3E inhibits tension development in smooth 
muscle tissues (Figure 11). The effects of expression of cofilin S3E and cofilin 
WT on contractile tension was evaluated 5 min after the stimulation of muscle 
tissues with 10–5 M ACh. The contractile force generated in response to 
stimulation with ACh was significantly inhibited in tissues expressing cofilin S3E. 
The mean tension in cofilin S3E–treated tissues was 52 ± 4.0% of force in 
untreated or WT–treated tissues (n = 27; p < 0.01). In contrast, the contractile 
force in tissues expressing the cofilin WT was not significantly different from force 
in untreated tissues (Figure 11A and 11B). 
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Figure 10. Dephosphorylation of both cofilin and ADF in response 
to ACh stimulation is inhibited by the expression of cofilin S3E in smooth 
muscle tissues. Immunoblots of ADF and cofilin isoforms obtained on extracts 
of ACh–stimulated and unstimulated (US) muscles after separation of proteins by 
two–dimensional electrophoresis. A. representative immunoblot from extracts of 
one unstimulated (US) and one stimulated (ACh) smooth muscle tissue after 
expression of cofilin S3E. Immunoblots were probed with anti–ADF/cofilin 
antibody (left), stripped, and reprobed with anti–cofilin antibody (right). B. mean 
values of the proportions of P–cofilin/cofilin and P–ADF/ADF in the muscle 
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extracts. All values are means ± S.E. Values for ACh and unstimulated groups 
are not significantly different (n = 4). 
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Figure 11. Expression of cofilin S3E inhibits contraction in tracheal 
muscle strips stimulated with 10–5 M ACh. A. representative isometric 
contractions in response to 10–5 M ACh obtained in three muscle strips from one 
experiment. Contractions were performed before and after a 2–day incubation 
with plasmids encoding cofilin wild type (cofilin WT), inactive mutant cofilin (cofilin 
S3E), or after incubation without plasmids (No plasmid). Contractile force in 
response to ACh was dramatically inhibited in tissues treated with plasmids 
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encoding inactive mutant cofilin S3E, but it was not depressed in tissues treated 
with plasmids encoding cofilin WT or tissues not treated with plasmids. B. mean 
force of muscle strips incubated without plasmids (No plasmids), with plasmids 
encoding cofilin WT, and plasmids encoding inactive mutant cofilin S3E. 
Isometric force was quantified as percentage of the normalized force in the no 
plasmid group. Values are means ± S.E. * force significantly different from no 
plasmid group. (n = 27, p < 0.05). 
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2.5. Expression of inactive mutant cofilin S3E inhibits actin polymerization 
in response to ACh (Figure 12). The effects of expression of cofilin S3E and 
cofilin WT on actin polymerization was evaluated. Smooth muscle strips 
incubated without plasmids or with plasmids encoding the cofilin S3E or cofilin 
WT were stimulated with 10–5 M ACh for 5 min, and the proportions of F–actin to 
G–actin in muscle extracts were analyzed by cell fractionation and immunoblot. 
Whereas ACh stimulation significantly increased the ratio of F–actin to G–actin in 
untreated and cofilin WT–treated smooth muscle strips (n = 6; p < 0.05), ACh 
stimulation did not significantly alter the ratio of F–actin to G–actin in smooth 
muscle tissues expressing inactive cofilin S3E (Figure 12A). In tissues treated 
with cofilin S3E, the ratio of F/G–actin was significantly elevated in unstimulated 
muscles and significantly depressed in ACh–stimulated muscles relative to 
untreated or cofilin WT treated muscles. 
The effect of ADF/cofilin inactivation on the pools of G–actin and F–actin 
was evaluated in cofilin S3E, cofilin WT, and untreated muscles (Figure 12B). 
Unstimulated muscles treated with cofilin S3E had significantly less G–actin and 
more F–actin than untreated or cofilin WT–treated muscles (n = 6, p < 0.05). 
Cofilin WT–treated muscles exhibited a small but statistically significant increase 
in G–actin and a decrease in F–actin compared with untreated muscles (n = 6, p 
< 0.05). The results suggest that expression of the cofilin S3E protein inhibited 
actin polymerization in muscle strips in response to ACh stimulation, and that 
cofilin S3E inhibited actin depolymerization in unstimulated muscle tissues. 
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Figure 12. Expression of cofilin S3E inhibits actin polymerization in 
tracheal muscle strips in response to ACh stimulation. A. mean ratios of F–
actin/ G–actin in muscle strips stimulated with ACh (solid bars) or unstimulated 
(US, open bars). ACh stimulation induced a significant increase in the ratio of F–
actin/G–actin in muscle strips treated with cofilin WT and in strips that did not 
undergo plasmid treatment (No plasmid). In muscle strips treated with the cofilin 
S3E plasmid, ACh stimulation did not significantly increase the ratio of F–
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actin/G–actin. The F–actin/G–actin ratio was also increased significantly in 
unstimulated muscle strips treated with cofilin S3E plasmid compared with no 
plasmid and cofilin WT–treated tissues. * significant difference from unstimulated 
tissues for each treatment group (n = 6, p < 0.05). ** significant difference from 
corresponding no plasmid group for unstimulated or ACh stimulated tissues. B. 
relative changes in the percent of G–actin and F–actin to total actin for each 
treatment group for unstimulated (US) and stimulated (ACh) muscles. Data are 
normalized to values for unstimulated muscles in the no plasmid treatment group. 
In the unstimulated muscles, the G–actin was lower and F–actin was higher in 
tissues treated with cofilin S3E. In muscles treated with cofilin WT, G–actin was 
higher, and F–actin was lower. * Significant difference from no plasmid, 
unstimulated group. In ACh–stimulated muscles treated with cofilin S3E, G–actin 
was higher, and F–actin was lower than in the muscle strips without plasmids or 
strips treated with cofilin WT. ** significant difference from no plasmid ACh–
stimulated group. Values are means ± S.E. (n = 6, p < 0.05). 
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 2.6. Expression of inactive cofilin S3E does not affect MLC 
phosphorylation in response to ACh in smooth muscle tissues (Figure 13). 
The effects of stimulation with ACh on MLC phosphorylation were compared in 
muscle tissues transfected with the plasmids encoding inactive cofilin S3E and 
cofilin WT and in tissues incubated with no plasmids. There were no significant 
differences in MLC phosphorylation in unstimulated or ACh stimulated muscles 
expressing the inactive cofilin S3E, cofilin WT, or muscles not treated with 
plasmids (n = 4, p < 0.05). Thus, the inhibition of contraction by cofilin S3E did 
not affect the signaling pathways that regulate MLC phosphorylation. 
 
2.7. Depletion of intracellular Ca2+ from muscle tissues or treatment of the 
tissues with calcineurin inhibitors inhibits the dephosphorylation of 
ADF/cofilin induced by ACh (Figure 14 and 15). Calcineurin, the Ca2+ –
dependent protein phosphatase 2B (PP2B), has been shown to regulate the 
activation of ADF/cofilin in several non−muscle cell lines (113; 187). The Ca2+ 
dependence of ADF/cofilin activation was evaluated by depleting intracellular 
Ca2+ from muscle tissues. Tissues were incubated in Ca2+ –free PSS containing 
0.1 mM EGTA. The tissues were then repeatedly stimulated for 5–min time 
periods with ACh until the contractile response decreased to a minimum (171). 
This generally required ~60 min and resulted in a reduction of isometric force to 
less than 10% of the maximal force. ADF/cofilin phosphorylation was then 
evaluated after ACh stimulation of the Ca2+ –depleted tissues for 5 min. The 
depletion of Ca2+ markedly inhibited the decrease in ADF/cofilin phosphorylation
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Figure 13. Expression of cofilin S3E does not inhibit the increase in 
MLC phosphorylation in response to ACh. Muscle tissues treated with 
plasmids encoding the cofilin WT or cofilin S3E, or not treated with plasmids (No 
Plasmid) were stimulated with 10–5 M ACh for 5 min and then frozen for the 
measurement of MLC phosphorylation. A. representative immunoblot showing 
unphosphorylated and phosphorylated MLC obtained from extracts of each of six 
muscle tissues with or without ACh from a single experiment. B. Mean values for 
MLC phosphorylation and force in ACh–stimulated no plasmid, cofilin WT, and 
cofilin S3E–treated muscles. No significant differences in MLC phosphorylation 
among the groups were detected, whereas force was significantly depressed in 
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cofilin S3E–treated tissues. Values shown are means ± S.E. * indicates 
significant difference from the no plasmid group (n = 4, p < 0.05). 
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stimulated by ACh (n = 6, p < 0.05) (Figure 14). This suggests that the 
dephosphorylation and activation of ADF/cofilin are mediated by Ca2+ –
dependent mechanisms in this tissue. 
Muscle tissues were incubated with the calcineurin inhibitors, cyclosporin 
A (10 μM) or deltamethrin (10 μM), for 2 h to evaluate the role of calcineurin in 
ADF/cofilin activation during active contraction with ACh (Figure 15). ADF/cofilin 
dephosphorylation was inhibited significantly in ACh–stimulated muscle tissues 
pretreated with calcineurin inhibitors (n = 5, p < 0.05). This suggests that the 
dephosphorylation and activation of ADF/cofilin are mediated by calcineurin in 
this tissue.  
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Figure 14. Depletion of intracellular Ca2+ inhibits cofilin 
dephosphorylation in response to ACh. A. immunoblots of phospho–
ADF/cofilin and cofilin in four muscle tissues stimulated with ACh for 5 min in 
normal Ca2+ or Ca2+ –free PSS containing 0.1 mM EGTA. B. Mean ratios for P–
ADF/cofilin/total cofilin for each treatment group. ADF/cofilin phosphorylation was 
significantly lower in ACh–stimulated muscle strips in normal calcium PSS; 
however, ADF/cofilin phosphorylation was not significantly different in ACh–
stimulated muscle tissues after depletion of intracellular Ca2+. * significantly 
different from unstimulated (US) muscles (n = 6, p < 0.05). All values are means 
± S.E. 
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Figure 15. Calcineurin inhibitors inhibit cofilin dephosphorylation in 
response to ACh. A. immunoblots of phospho–ADF/cofilin and cofilin in six 
muscle tissues treated with calcineurin inhibitors, cyclosporin A, or deltamethrin 
10 μM for 2 h and then stimulated with ACh for 5 min or left unstimulated (US). B. 
Mean ratios for P–ADF/cofilin/cofilin for each treatment group. ADF/cofilin 
phosphorylation was significantly lower in ACh–stimulated muscle strips without 
calcineurin inhibitors; however, cofilin phosphorylation was not significantly 
different in ACh–stimulated muscle tissues with calcineurin inhibitors. C. mean 
force of muscle strips incubated without calcineurin inhibitors and with calcineurin 
inhibitors (cyclosporin A or deltamethrin). Isometric force was quantified as 
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percentage of the normalized force in the no plasmid group. * Significantly 
different from unstimulated muscles in same treatment group (n = 5, p < 0.05). 
Values are means ± S.E. 
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Discussion 
The results provide the first documentation that the activation of 
ADF/cofilin is necessary for the development of active contractile tension in 
smooth muscle. Previous studies have shown that active tension development in 
tracheal smooth muscle depends on the polymerization of a small pool of actin, 
and that this actin polymerization is catalyzed by activation of the Arp2/3 complex 
(74; 114; 198; 199). In this study, we found that endogenous cofilin and ADF are 
both significantly (~40%) phosphorylated on serine 3 in unstimulated tracheal 
muscle tissues. Stimulation of the tissues with either ACh or KCl results in a 70% 
reduction in the phosphorylation of both cofilin and ADF, indicating they are 
undergoing activation. The time course of ADF/cofilin dephosphorylation in 
response to contractile stimulation was well correlated with the time course of the 
smooth muscle tension development (Figure 7). Both force development and 
actin polymerization induced by stimulation with acetylcholine were inhibited in 
tracheal muscles by the expression of an inactive cofilin phosphomimetic, cofilin 
S3E. Cofilin S3E inhibited the dephosphorylation of endogenous cofilin and ADF 
in muscle tissues, thereby preventing their activation. The expression of cofilin 
S3E did not affect myosin light chain phosphorylation, indicating that the 
inhibition of tension development caused by the expression of cofilin S3E did not 
result from an inhibitory effect of ADF/cofilin inactivation on pathways that 
regulate the activation of myosin. These observations suggest that the regulation 
of ADF/cofilin activation through its dephosphorylation may provide an important 
mechanism for modulating tension development in smooth muscle tissues that is 
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independent of the pathways that regulate actomyosin activation and cross–
bridge cycling. 
Although a role for ADF/cofilin in muscle contraction has not been 
previously described, the importance of ADF/cofilin for cell motility is well 
established (15; 28; 35). Movement of a cell involves the generation of branched 
actin filaments at the leading edge of the cell and the disassembly of actin at the 
rear of the actin network through concerted processes mediated by actin–
polymerizing and actin–depolymerizing factors (85). ADF/cofilin plays an 
essential role in both the actin polymerization and depolymerization processes 
during cell movement. It promotes actin disassembly by severing actin filaments 
and by accelerating the off–rate of actin monomers from the pointed ends of actin 
filaments (28). The severing of actin filaments increases the number of free 
barbed filament ends, which promotes the dendritic nucleation of new actin 
filaments by the Arp2/3 complex (86). By enhancing the disassembly of actin 
filaments from the pointed end of the filament, ADF/cofilin also contributes to 
actin filament assembly by replenishing the actin monomer pool required for 
polymerization (17; 93; 141). 
Evidence from studies of a variety of types of smooth muscle tissues and 
cells has shown that contractile stimulation catalyzes the formation of additional 
F–actin, and that the polymerization of actin is a necessary step in tension 
generation (10; 20; 33; 74; 80; 88; 91; 114; 199). In tracheal smooth muscle, 
contractile stimulation causes activation of the Arp2/3 complex mediated by the 
actin–nucleating protein, N–WASp (neuronal Wiskott–Aldrich syndrome protein). 
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The inhibition of N–WASp–induced Arp2/3 complex activation inhibits stimulus–
induced actin polymerization and tension development, without affecting myosin 
light chain phosphorylation (199). Although the role of the newly polymerized 
actin in regulating the contractile function of intact smooth muscle tissues is 
currently unclear, there is evidence that actin polymerization occurs 
submembranously in the cortex of the cell (74; 198; 199; 201). It is possible that 
a network of submembranous actin forms to increase the rigidity of the 
membrane during tension development and to strengthen membrane adhesion 
complexes that are involved in transmitting force between the contractile 
apparatus and the outside of the cell (74; 198; 201). 
Many isoforms of tropomyosin, including muscle–specific isoforms, 
physiologically inhibit actin filament dynamics and the actin depolymerization and 
severing caused by ADF/cofilin; thus tropomyosin may serve to spatially 
segregate stable actin filaments from dynamic subsets of actin filaments (22; 23; 
37; 43; 103; 127; 138). In smooth muscle, most of the filamentous actin that is 
associated with myosin is believed to be bound to tropomyosin (102); thus, it is 
likely that ADF/cofilin associates with a pool of actin that is not part of the 
contractile apparatus. This actin could reside within a dynamic submembranous 
pool of actin that undergoes rapid reorganization during changes in smooth 
muscle activation. Although there are uncertainties regarding the function of 
stimulus–induced actin polymerization in differentiated smooth muscle tissues, it 
is clear that many aspects of the molecular processes involved in the actin 
polymerization process are analogous to the processes that regulate actin 
 59
network assembly and disassembly at the leading edge of motile cells.  
We found that the expression of inactive cofilin SE3 in tracheal muscle 
inhibited the dephosphorylation of endogenous cofilin and endogenous ADF in 
response to stimulation with ACh, thus inhibiting their activation (Figure. 9 and 
10). The cofilin S3E mutant is a phosphomimetic, with glutamate substituted at 
the serine 3 site. Its actin severing ability is negligible because it has minimal 
capability for binding to F–actin (113). Our observations are consistent with those 
of Konakahara et al. (96) who found that the expression of the cofilin S3E mutant 
in a hematopoietic progenitor cell line caused the inactivation of endogenous 
cofilin and inhibition of the rapid turnover of actin filaments needed for cell 
migration. The introduction of plasmids encoding either wild type cofilin or cofilin 
S3E into tracheal smooth muscle tissues increased the amount of total cofilin in 
the tissues by ~70%. 
There are several possible mechanisms by which cofilin S3E might 
inhibit endogenous ADF/cofilin dephosphorylation and activation. Cofilin S3E 
competes with phosphorylated cofilin and ADF for localization to sites where they 
are activated (150). Cofilin S3E may also compete with endogenous ADF/cofilin 
for binding to the ADF/cofilin–specific phosphatase, Slingshot, thereby preventing 
the activation of endogenous ADF/cofilin (96). 
In unstimulated muscle tissues, the expression of cofilin S3E significantly 
decreased the pool of G–actin and increased the pool of F–actin, suggesting that 
ADF/cofilin inactivation may inhibit actin depolymerization (Figure 12). 
Expression of cofilin S3E in the tissues also inhibited the increase in F–actin that 
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occurs when the tissues are stimulated with acetylcholine. The inhibitory effect of 
cofilin S3E on stimulus–induced actin polymerization may reflect the absence of 
an adequate pool of G–actin, an inadequate number of actin filament barbed 
ends available for interaction with the Arp2/3 complex, or both. In the tracheal 
muscle tissues, activated ADF/cofilin may act collaboratively with the Arp2/3 
complex to regulate actin polymerization during contractile activation by 
processes analogous to those that occur during cell migration (199). 
In previous studies of smooth muscle actin dynamics, we and others 
have found that the inhibition of actin polymerization by latrunculin or by 
molecular interventions that interrupt the actin polymerization process results in a 
marked inhibition of active tension development without significantly affecting 
MLC phosphorylation (74; 114; 170; 173; 199). These studies suggested that 
actin polymerization functions in the regulation of tension development 
separately from and independently of the activation of myosin ATPase activity 
and cross–bridge cycling. Our present results are consistent with our previous 
observations in that the inhibition of actin polymerization by inactive cofilin S3E 
had no effect on the increase in MLC phosphorylation in response to agonist 
stimulation. Thus the inhibition of active force development by cofilin S3E during 
contractile stimulation appears to result directly from the inhibition of actin 
polymerization rather than from effects on MLC phosphorylation or cross–bridge 
cycling. This is consistent with the possibility that the dynamic pool of actin in 
smooth muscle is separate from the actin filaments that interact with myosin and 
participate in actomyosin cross–bridge cycling. 
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Wild type cofilin was expressed in the tissues to verify that the effects of 
cofilin S3E overexpression on actin dynamics and contractile function resulted 
from ADF/cofilin inactivation rather the overexpression of cofilin protein. We 
found that the overexpression of wild type cofilin resulted in increases in both 
inactive phosphorylated cofilin and active cofilin, but the ratio of phospho–cofilin 
to cofilin was not significantly different from that in the untreated tissues (Figure 
9). The dephosphorylation and activation of the ADF/cofilin in the tissues 
expressing wild type cofilin during contractile stimulation with ACh was also 
similar to that in untreated tissues. Tissues transfected with the wild type cofilin 
plasmid exhibited very small but significant differences in the proportions of F– 
and G–actin before contractile stimulation, suggesting that the increased amount 
of active cofilin was causing a small increase in actin depolymerization; however, 
we did not observe a statistically significant effect on the proportions of F– and 
G–actin after contractile stimulation (Figure 12). Actin polymerization and force 
development depend on the cooperation of actin regulatory proteins such as N–
WASp and the Arp2/3 complex, which may limit the effects of cofilin 
overexpression on actin dynamics. 
In non–muscle cells, LIM kinases and TES (testicular) protein kinases 
have been identified as specific mediators of ADF/cofilin phosphorylation at Ser–
3 (13; 148; 193). LIM kinases are activated by extracellular stimuli and are 
downstream of small Rho family GTPases and their downstream protein kinases 
PAK and ROCK, whereas TES kinases are downstream of integrin signaling 
pathways. ADF/cofilin dephosphorylation is regulated by Slingshot phosphatases 
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via multiple signaling pathways, which may be activated by cell type and 
stimulus–specific signaling pathways (85). 
In this study, we showed that the activation of ADF/cofilin by 
dephosphorylation is required for actin polymerization and tension development 
in tracheal smooth muscle tissues in response to stimulation with the contractile 
agonist ACh. Previous studies of tracheal smooth muscle tissues demonstrated 
that contractile stimulation with ACh increases the activation of the small GTPase, 
Cdc42, and that Cdc42 activation is necessary for tension generation and actin 
polymerization (170). ACh also stimulates the activation of the small GTPase, 
RhoA, in this tissue (115). As ADF/cofilin dephosphorylation (activation) occurs 
concurrently with the ACh induced activation of these small GTPases in tracheal 
muscle, the phosphorylation of ADF/cofilin in response to ACh in this tissue might 
not be stimulated by kinases activated downstream of these GTPases. 
Membrane–depolarizing concentrations of KCl elicited a decrease in 
ADF/cofilin phosphorylation in tracheal muscle tissues (Figure 7). We also found 
that ACh–induced ADF/cofilin dephosphorylation was inhibited in muscles that 
were depleted of intracellular Ca2+ or that were treated with inhibitors of the Ca2+ 
–dependent phosphatase, calcineurin (PP2B) (Figure 14 and 15). These 
observations indicate that the pathways regulating the activation of ADF/cofilin in 
tracheal smooth muscle in response to stimulation with ACh are mediated by a 
pathway requiring the Ca2+ –dependent activation of calcineurin. These results 
are consistent with studies in several cultured non–muscle cell lines 
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demonstrating that the Ca2+ –dependent dephosphorylation of cofilin by the 
Slingshot phosphatases requires activation of calcineurin (113; 187).  
In conclusion, this study demonstrates that ADF/cofilin is 
dephosphorylated and activated by the contractile stimulation of smooth muscle 
tissues, and that the activation of ADF/cofilin is required for actin polymerization 
and tension development during contractile stimulation. In tracheal smooth 
muscle tissues, ADF/cofilin may regulate the dynamics of a pool of actin that is 
distinct from tropomyosin–bound actin that interacts with myosin and participates 
in cross–bridge cycling. Although the function of actin polymerization in smooth 
muscle is uncertain, our results suggest that the regulation of ADF/cofilin 
phosphorylation provides a distinct process for modulating tension generation in 
smooth muscle that is independent of the pathways that regulate myosin light 
chain phosphorylation and cross–bridge cycling. 
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CHAPTER II 
II. ii 
The signaling pathways that regulate activation of ADF/cofilin  
in canine tracheal smooth muscle tissues 
 
1. Summary 
In the previous study, the role of ADF/cofilin in the regulation of the 
airway smooth muscle tissue actin dynamics and contraction was evaluated. In 
the present study, I focused on the signaling pathways that regulate cofilin 
activation.  
In cultured neural cell lines, ADF/cofilin can  be activated by 
dephosphorylation stimulated by cAMP and dephosphorylation of ADF/cofilin can 
be inhibited by the non–specific phosphatase, PP1 or PP2A (protein 
phosphatase 1 or protein phosphatase 2A) inhibitor, calyculin A, which suggest 
that the cAMP induced dephosphorylation of ADF/cofilin may be through cAMP–
PKA–PP1/PP2A pathway  (113). In human embryonic kidney (293T) cell and 
human cervical cancer (HeLa) cells, cofilin has been shown to be activated by 
the ADF/cofilin–specific protein phosphatase SSH (85), which was regulated by 
calcium–dependent phosphatase, calcineurin (187). Recent evidence shows that 
isoproterenol or forskolin led to a significant decrease in the phosphorylation of 
cofilin in bovine airway smooth muscle cells and bovine pulmonary artery 
endothelial cells (58; 95), however, the downstream pathway by which cAMP 
activates cofilin was not determined. However, there is no information regarding 
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the pathways regulating cofilin activation in smooth muscle tissues. Even at the 
cellular level, information on the signaling pathways that regulate ADF/cofilin 
activation is limited.  
We hypothesized that phosphatases activate ADF/cofilin airways smooth 
muscle tissues in response to ACh stimulation. To evaluate this hypothesis, we 
used an slingshot inactive phosphatase mutant, SSH1L C393S (99), to 
determine whether slingshot could activate cofilin in response to ACh. We also 
evaluated the effects of forskolin, an activator of the enzyme adenylyl cyclase, on 
the regulation of ADF/cofilin activity and actin polymerization in airway smooth 
muscle tissues.  
Our results demonstrate that ADF/cofilin dephosphorylation in response to 
ACh is inhibited by the inactive phosphatase slingshot mutant, SSH1L C393S, 
indicating that cofilin activation is regulated by slingshot and that the activity of 
slingshot may be regulated by Ca2+–dependent calcineurin pathway (187).   We 
also find that ADF/cofilin undergoes dephosphorylation in response to forskolin 
stimulation in smooth muscle tissues. In contrast to ACh, the activation of cofilin 
by forskolin does not appear to be regulated by calcineurin. Our results also 
suggest that the activation of ADF/cofilin is a required for the dynamic 
reorganization of actin during both the contraction and the relaxation of airway 
smooth muscle tissues. 
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2. Results 
2.1. ADF/Cofilin activation (dephosphorylation) and force development 
were inhibited in smooth muscle tissues treated with the inactive 
phosphatase slingshot mutant plasmid, SSH1L C393S. pcDNA3.1 vectors 
(human cytomegalovirus as promoter) encoding human the inactive phosphatase 
slingshot1 mutant C393S (SSH1L C393S) and slingshot wild type (SSH1L WT) 
(Figure 16) were introduced into smooth muscle strips by reversible 
permeabilization. Transfected tissues and sham–treated tissues (no plasmid) 
were then maintained in an incubator for 2 days to allow for the expression of 
recombinant proteins. Muscle tissues were measured the force development in 
response to ACh stimulation and finally stimulated with 10–5 M ACh for 5 min or 
left unstimulated and then frozen for the analysis of ADF/cofilin phosphorylation 
on Ser–3. 
The effect of SSH1L C393S and SSH1L WT on stimulus–induced 
ADF/cofilin activation in tracheal smooth muscle was determined by western blot 
in extracts from unstimulated and stimulated muscle tissues expressing the 
SSH1L C393S (Figure 17A and 17B) and SSH1L WT (Figure 17C and 17D) 
respectively. ACh induced a significant decrease in ADF/cofilin phosphorylation 
in tissues not treated with plasmids (n = 5, p < 0.05) or treated in SSH1L WT (n = 
2, p < 0.05). Expression of the SSH1L C393S markedly inhibited the ADF/cofilin 
dephosphorylation in response to stimulation with ACh (Figure 17, n = 5， p < 
0.05).  
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Figure 16. The structure of slingshot1L wild type and inactive 
phosphatase slingshot1L mutant. Cysteine 393 of slingshot is the critical site for 
regulating binding to the phospho–ADF/cofilin. In the inactive phosphatase 
slingshot1L mutant (SSH1L C393S), cysteine 393 is replaced by serine. The 
inactive phosphatase slingshot mutant (SSH C393S) forms an irreversible 
enzyme–substrate complex with phospho–ADF/cofilin and thereby inhibits the 
endogenous slingshot from binding to phospho–ADF/cofilin (99).  
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Figure 17.  Expression of SSH1L C393S inhibits dephosphorylation 
of ADF/cofilin and force development in response to Ach in smooth muscle 
tissues. A. Representative immunoblot of extracts from 4 smooth muscle tissues 
treated with plasmids encoding inactive phosphatase slingshot mutant (SSH1L 
C393S), or from tissues not treated with plasmids (No Plasmid). Immunoblots 
were probed with antibodies to phospho ser–3 ADF/cofilin, cofilin. B. Mean 
values for Phospho–ADF (P–ADF/cofilin) in muscle strips without plasmid (no 
plasmid) or expressing SSH1L C393S stimulated with ACh or unstimulated (US).  
Values are normalized to the No Plasmid US. C. Representative immunoblot of 
extracts from 4 smooth muscle tissues treated with plasmids encoding wild type 
slingshot (SSH1L WT), or from tissues not treated with plasmids (No Plasmid). 
Immunoblots were probed with antibodies to phospho ser–3 ADF/cofilin, cofilin. D. 
Mean values for Phospho–ADF (P–ADF/cofilin) in muscle strips without plasmid 
(no plasmid) or expressing SSH1L WT stimulated with ACh or unstimulated (US).  
Values are normalized to the No Plasmid US. group. All values are means ± 
S.E.M. * Significantly different from US group for the same treatment (n = 2, p < 
0.05). E. Representative isometric contractions in response to 10–5 M ACh 
obtained in 3 muscle strips from one experiment. Contractions were performed 
before and after 2–day incubation with plasmids encoding inactive phosphatase 
slingshot mutant (SSH1L C393S) or slingshot wild type (SSH1L WT), or after 
incubation without plasmids (No plasmid). Contractile force in response to10–5 M 
ACh was dramatically inhibited in tissues treated with plasmids encoding inactive 
phosphatase mutant SSH (SSH1L C393S), but it was not depressed in tissues 
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not treated with plasmids or treated with slingshot wild type (SSH1L WT) 
plasmids. F. Mean force of muscle strips incubated without plasmids (No 
plasmids), with plasmids encoding inactive phosphatase mutant SSH (SSH 
C393S). Isometric force was quantified as percentage of the normalized force in 
the No plasmid group. Values are means ± SEM. * Force significantly different 
from No Plasmid group. (n = 2–5, p < 0.05). 
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SSH1L C393S significantly inhibited contractile force in response to 5 
min stimulation with 10–5 M ACh relative to sham–treated smooth muscle tissues 
and SSH1L WT treated tissues (Figure 17E and 17F) (n = 2–5, p < 0.05). 
 
2.2. Forskolin prevents actin polymerization induced by ACh in tracheal 
smooth muscle tissues (Figure 18). The effect of forskolin on actin 
polymerization was evaluated. Smooth muscle strips were stimulated with 10–5 M 
ACh for 5 min, and then treated with 10–5 M forskolin for 30 min. Control tissues 
were treated with ACh alone for the same time period.  Then the proportions of 
F–actin to G–actin in muscle extracts were analyzed by cell fractionation and 
immunoblot. Whereas 10–5 M ACh stimulation significantly increased the ratio of 
F–actin to G–actin in smooth muscle strips not treated with forskolin (n = 6; p < 
0.05), ACh stimulation did not significantly alter the ratio of F–actin to G–actin in 
smooth muscle tissues treated with forskolin. The results indicate that forskolin 
inhibits actin polymerization in muscle strips in response to ACh stimulation.  
 
2.3. Forskolin induced ADF/cofilin dephosphorylation on Ser–3 and 
relaxation in tracheal smooth muscle tissues (Figure 19). The effect of 
forskolin on ADF/cofilin dephosphorylation on Ser–3 was evaluated. Eight canine 
tracheal smooth muscle strips were maintained for 30 min without contractile 
stimulation and then half of the muscle strips were treated with 0, 10, 30, or 100 
μM forskolin for 30 min, while the other half of the muscle strips were stimulated 
with 10–5 ACh for 5 min and then treated with 0, 10, 30, or 100 μM forskolin for 30 
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Figure 18. Forskolin reversed the actin polymerization in tracheal 
smooth muscle tissues. A. Representative immunoblot of extracts from 4 
smooth muscle tissues unstimulated (US), stimulated with ACh, stimulated with 
10–5 M forskolin (FSK), or stimulated with 10–5 M ACh for 5 min followed by  10–5 
M forskolin (FSK) for 30 min. Immunoblots were probed with antibodies to total 
actin. B. Mean ratios of F–actin/G–actin for each treatment group. ACh 
stimulation induced a significant increase in the ratio of F–actin/G–actin in 
smooth muscle strips not treated with forskolin. In muscle strips treated with 
forskolin alone, the ratio of F–actin to G–actin was similar to that in unstimulated 
tissues. Stimulation by forskolin reversed the increase the ratio of F–actin to G–
actin caused by ACh stimulation. * significant difference from corresponding US 
no FSK muscles in same treatment group. (n = 6, P < 0.05). 
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Figure 19. Forskolin induced ADF/Cofilin dephosphorylation on 
Ser–3 in tracheal smooth muscle tissues. A. Representative immunoblot of 
extracts from 8 smooth muscle tissues. Half of the muscle strips were not 
stimulated with ACh, but treated with 0, 10, 30, or 100 μM forskolin for 30 min, 
while the rest half of the muscle strips were stimulated with 10–5 ACh for 5 min 
and then followed with 0, 10, 30, or 100 μM forskolin for 30 min. Immunoblots 
were probed with antibodies to phospho ser–3 ADF/cofilin, cofilin. B. Mean 
values for Phospho–ADF (P–ADF)/cofilin and tension development in muscle 
strips treated without forskolin or forskolin (FSK) 10, 30, 100 μM for 30 min.  
Values are normalized to no ACh and no forskolin treated group. All values are 
means ± S.E.M. * Significantly different from no forskolin treated group (n = 6, p < 
0.05). 
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min. ADF/cofilin phosphorylation on Ser–3 and force development were elevated 
in the above smooth muscle tissues. ADF/cofilin was dephosphorylated 
significantly in smooth muscle tissues treated with forskolin alone or treated 
with10–5 M ACh for 5 min and then followed with forskolin (Figure 19A and 19B), 
and forskolin significantly decreased the force development in response to ACh 
stimulation (Figure 19B) (n = 6; p < 0.05).   
 
2.4. Depletion of intracellular Ca2+ from muscle tissues does not 
inhibit the dephosphorylation of ADF/cofilin induced by forskolin (Figure 
20). The Ca2+ –dependence of ADF/cofilin activation induced by forskolin was 
evaluated by depleting intracellular Ca2+ from muscle tissues. Tissues were 
incubated in Ca2+ –free PSS containing 0.1 mM EGTA. The tissues were then 
repeatedly stimulated for 5–min time periods with ACh until the contractile 
response decreased to a minimum (171). This generally required ~60 min and 
resulted in a reduction of isometric force to less than 10% of the maximal force. 
ADF/cofilin phosphorylation was then evaluated in the Ca2+ –depleted tissues 
incubated in PSS without forskolin or with 10–5 M forskolin for 30 min. The 
depletion of Ca2+ did not prevent the decrease in ADF/cofilin phosphorylation 
stimulated by forskolin but it prevented the ADF/cofilin dephosphorylation 
stimulated by ACh (n = 6, p < 0.05). This suggests that the dephosphorylation 
and activation of ADF/cofilin induced by forskolin is mediated by Ca2+ –
independent mechanisms in tracheal smooth muscle tissue. 
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Figure 20. Forskolin induced ADF/cofilin dephosphorylation in 
tracheal smooth muscle tissues which is calcium insensitive. A. 
Representative immunoblot of extracts from 8 smooth muscle tissues of normal 
Ca2+ PSS or Ca2+ depletion PSS (Ca2+ free), The first 4 muscle strips were 
unstimulated (US), stimulated with 10–5 M ACh, stimulated with 10–5 M forskolin 
(FSK), or first simulated with 10–5 M ACh 5 min then followed by 10–5 M forskolin 
(ACh&FSK ) for 30 min; the another 4 muscle strips are depleted with 
intracellular calcium (Ca2+ free) and then were unstimulated (US), stimulated with 
10–5 M ACh, stimulated with 10–5 M forskolin (FSK), or first simulated with 10–5 M 
ACh 5 min then followed by 10–5 M forskolin (ACh&FSK) for 30 min. Immunoblots 
were probed with antibodies to phospho–ADF/cofilin at serine 3, cofilin. B. Mean 
ratios of phospho–ADF (P–ADF)/cofilin to cofilin for each treatment group. 
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Values are normalized to US group. All values are means ± S.E.M. * Significantly 
different from muscles of normal Ca2+ PSS in the same treatment group (n = 6, p 
< 0.05). 
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2.5. ADF/cofilin activation induced by forskolin is not mediated by 
calcium–dependent calcineurin in the tracheal smooth muscle tissues 
(Figure 21). The calcineurin inhibitors, cyclosporin A (10μM) and deltamethrin 
(10μM) were applied to evaluate whether the ADF/cofilin dephosphorylation 
induced by forskolin is mediated by calcineurin. The muscle strips were treated 
without inhibitors (No In), with cyclosporin A (10 μM) (CycloA), or with 
deltamethrin (10 μM) (Delta) for 2 hours and then stimulated with 10–5 M forskolin 
(FSK) or not stimulated for 30 min. ADF/cofilin phosphorylation was then 
evaluated. The calcineurin inhibitors did not prevent the ADF/cofilin 
dephosphorylation induced by forskolin in tracheal smooth muscle (n = 5, p < 
0.05). This suggests that forskolin did not activate ADF/cofilin through calcium–
calcineurin pathway.  
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Figure 21. ADF/cofilin activation induced by forskolin is not 
through calcium–dependent calcineurin in the tracheal smooth muscle 
tissues. A. Representative immunoblot of extracts from 12 smooth muscle 
tissues, The first 6 muscle strips were double treated respectively with no 
inhibitors (No), cyclosporin A (10μM) (C), deltamethrin (10μM) (D) for 2 hours, 
the another 6 muscle strips were treated in the similar way and then followed by 
10–5 M forskolin (FSK) for 30 min. Immunoblots were probed with antibodies to 
phospho–ADF/cofilin at serine 3, cofilin. B. Mean ratios of phospho–ADF (P–
ADF)/cofilin to cofilin for each treatment group. Values are normalized to US 
group. All values are means ± S.E.M. * Significantly different from muscles 
without no inhibitor (No In) and not followed by forskolin (FSK) in the same 
treatment group (n = 5, p < 0.05).   
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Discussion 
The present results provide the first documentation for the regulation of  
the activation of  ADF/cofilin is by specific  phosphatases (130; 137; 168) during 
airway smooth muscle contraction with ACh stimulation.  The inactive 
phosphatase slingshot1 mutant, SSH1L C393S, was designed as the dominant 
negative mutant (99; 168) by replacing cysteine–393 with serine. SSH1L C393S 
can form a stable enzyme–substrate complex with phospho–ADF/cofilin, thus it 
can inhibit the dephosphorylation of cofilin by endogenous phosphatases by 
sequestering phospho–ADF/cofilin. When the SSH1L C393S was expressed in 
smooth muscle tissues, force development and ADF/cofilin 
dephosphorylation/activation induced by acetylcholine was inhibited. This 
confirmed the hypothesis that phosphatases regulate ADF/cofilin activation in 
smooth muscle tissues in response to ACh stimulation. Combined with my 
previous observations (section II.i.), these results suggest that ACh–induced 
ADF/cofilin activation in airway smooth muscle tissues may be through a 
calcium–calcineurin–SSH pathway (202). Mizuno and colleagues demonstrated 
that in HeLa cells, ADF/cofilin is dephosphorylated/activated in response to Ca2+ 
ionophore A23187 and Ca2+–mobilizing agonists, ATP and histamine, through a 
calcium–calcineurin–SSH pathway (187). 
In results described previously (section II.i.), my data indicated that 
active ADF/cofilin is required for actin polymerization and force development in 
airway smooth muscle (202). The smooth muscle relaxant, forskolin, also 
dephosphorylates and activates ADF/cofilin but it prevents actin polymerization 
 81
during airway smooth muscle contraction. Similar results have been reported in 
cultured cells: Emala and colleagues reported that isoproterenol, a β–receptor 
agonist, induced actin depolymerization in cultured human airway smooth muscle 
cells (82). It was also reported that elevated cAMP can activate cofilin in bovine 
artery endothelial cells and bovine airway smooth muscle cells(58; 95). My 
results support the hypothesis that active ADF/cofilin is necessary for actin 
dynamics that occurs during both contraction and relaxation of airway smooth 
muscle. Whether active ADF/cofilin promotes actin polymerization or not may 
depend on the availability of actin subunits within the region of the cell where this 
process occurs, and the activation state of proteins involved in the actin 
polymerization process, such as N–WASp (35). My studies also suggest that the 
effect of ADF/cofilin activation on actin dynamics is not the same for all stimuli, as 
indicated by in vitro studies of ADF/cofilin (35).  Active ADF/cofilin may generate 
free barbed ends on actin filaments, which will depolymerize in the presence of 
relaxants, such as forskolin, due to the absence of other factors that promote 
actin polymerization. My preliminary results suggest that active ADF/cofilin can 
sever the actin filaments and generate free barbed ends, but whether actin 
polymerization or depolymerization occurs depends on the upstream signals. 
I have also evaluated the signaling pathways that regulate the activation 
of ADF/cofilin in response to forskolin stimulation, which induces airway smooth 
muscle relaxation. Previous studies on neural cells, vascular endothelial cells 
and bovine airway smooth muscle cells have suggested that elevated cAMP can  
lead to the activation of ADF/cofilin  (58; 95; 113), but there are almost no studies 
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that demonstrate how cAMP activates ADF/cofilin. In the above studies, Meberg 
PJ. et al. (113) and Goeckeler ZM. et al. (58) respectively used an inhibitor 
(calyculin A) of the non–specific phosphatase, PP1 or PP2A (protein 
phosphatase 1 or protein phosphatase 2A) to prevent cofilin activation induced 
with by cAMP in neural cells and bovine artery endothelial cells. This evidence 
suggests that the dephosphorylation of ADF/cofilin induced by cAMP may be 
through PP1/PP2A. Our results suggest that forskolin can activate ADF/cofilin 
through a calcium–independent pathway. Depletion of intracellular Ca2+ from 
smooth muscle tissues does not inhibit the activation of ADF/cofilin induced by 
forskolin, but it does inhibit cofilin activation in response to contractile stimulation 
with ACh. This suggests that activation of ADF/cofilin during smooth muscle 
relaxation induced by forskolin is Ca2+ –independent.   
In results described previously (section II.i.), I found that ACh stimulation 
induced ADF/cofilin dephosphorylation through a calcium–calcineurin dependent 
pathway. Thus, calcineurin inhibitors were applied to evaluate whether 
ADF/cofilin activation induced by forskolin is mediated by calcineurin. My results 
showed calcineurin inhibitors did not prevent ADF/cofilin activation induced by 
forskolin. This suggests that forskolin activates ADF/cofilin by a different 
mechanism than ACh in airway smooth muscle tissues. 
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CHAPTER III 
Perspectives 
 
Airway hyperresponsiveness is the fundamental mechanism of asthma 
and reorganization of actin filament network may be involved in this process. 
There is extensive evidence that actin polymerization is initiated by contractile 
stimulation in smooth muscle and this actin polymerization is required for active 
contraction (10; 20; 33; 80; 114; 173).  The increase in the proportion of 
filamentous actin that occurs in response to the stimulation of smooth muscle 
cells and the essential role of stimulus–induced actin polymerization in the 
generation of mechanical tension have been convincingly documented in many 
smooth muscle tissues and cells using a wide variety of experimental 
approaches (55; 74). There is also extensive evidence that the functional role of 
actin polymerization during contraction is distinct and separately regulated from 
the actomyosin cross–bridge cycling process. However, much more data will be 
needed to establish the molecular basis for the regulation of actin polymerization 
and its functional roles in diverse types of smooth muscle cells and tissues.  
ADF/cofilin is a critical factor in regulating actin dynamics. The first study 
(Chapter II.i.) addressed the hypothesis that the activation of ADF/cofilin is 
necessary in smooth muscle contraction and actin polymerization. To address 
this objective, the roles of ADF/cofilin in regulating actin polymerization in smooth 
muscle in response to extracellular stimuli were determined. The 
phosphomimetic mutant of cofilin, cofilin S3E, which can inhibit the endogenous 
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activation of the ADF/cofilin and actin polymerization in vitro studies, was 
expressed in muscle strips to inhibit the activation of the endogenous ADF/cofilin.  
Expression of the cofilin S3E may inhibit endogenous ADF/cofilin 
dephosphorylation by competitively binding to the ADF/cofilin specific 
phosphatase, slingshot. This inhibition of the ADF/cofilin activation caused by 
cofilin S3E inhibited actin polymerization and tension development in response to 
ACh, but it does not affect MLC phosphorylation in the smooth muscle tissues. 
These results suggest active ADF/cofilin is necessary for agonist–induced actin 
polymerization and tension development in smooth muscle. 
In a separate set of studies (Chapter II.ii.), I evaluated the pathways that 
regulate the activation of ADF/cofilin during smooth muscle contraction. To 
address this objective, the SSH1 dominant negative mutant, SSH1L C393S, was 
introduced in muscle strips to inhibit the activation of the endogenous ADF/cofilin.  
The inhibition of the ADF/cofilin activation caused by SSH1L C393S inhibited 
tension development in response to ACh in the smooth muscle tissues. These 
results suggest activation of ADF/cofilin in response to contractile stimuli is 
regulated by phosphatases.  
The role of active ADF/cofilin in the regulation of actin polymerization 
during smooth muscle relaxation and the pathways that activate ADF/cofilin 
during smooth muscle relaxation were also evaluated. The activator of adenylyl 
cyclase, forskolin, was used to determine the role of ADF/cofilin in smooth 
muscle relaxation and actin depolymerization and the pathways that activate 
ADF/cofilin during smooth muscle relaxation. These results suggest ADF/cofilin is 
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activated during smooth muscle relaxation, and that actin polymerization is 
inhibited. This pathway that activates ADF/cofilin on response to forskolin was 
not calcium–dependent.  
In conclusion, actin polymerization initiated by contractile stimulation and 
actin depolymerization initiated by relaxing stimulation in smooth muscle tissues 
both require active ADF/cofilin activation (Figure 22).  
However, there are some interesting questions that need to be explored 
further. The first question is whether nonspecific phosphatases, such as 
calcineurin (PP2B), regulate slingshot activation. Since the inactive phosphatase 
slingshot mutant can prevent the endogenous slingshot from binding with the 
phospho–ADF/cofilin, it can also inhibit other nonspecific phosphatases by a 
similar mechanism. Thus, knockdown the endogenous slingshot by introducing 
the siRNA of slingshot would establish whether slingshot is the only phosphatase 
that directly dephosphorylates cofilin. If the ADF/cofilin dephosphorylation is 
inhibited by knocking down slingshot, it will suggest that slingshot activity is 
required for the regulation of ADF/cofilin activation in airway smooth muscle, and 
that other phosphatases act upstream of slingshot. The measurement of 
slingshot activity in vitro with a calcineurin inhibitor or a dominant negative 
calcineurin mutant (187) would also provide evidence as to whether calcineurin 
activates slingshot. However, based on my present results it is unclear whether 
or not calcineurin directly dephosphorylates cofilin. 
Secondly, the pathways that regulate cofilin activation induced by 
forskolin are not yet clear. However, in airway smooth muscle, the activation of
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Figure 22. The role of active ADF/cofilin in smooth muscle force 
development. The activation of ADF/cofilin regulates actin dynamics, which is 
required for tension development in smooth muscle tissues.  
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ADF/cofilin induced by forskolin appears to be mediated by a Ca 2+ insensitive 
mechanism that does not involve calcineurin. The role of slingshot in forskolin 
activated ADF/cofilin dephosphorylation is currently unknown. The first step is to 
knockdown slingshot by introducing the siRNA against slingshot. Then the 
dephosphorylation of ADF/cofilin can be evaluated. If expression of slingshot 
siRNA prevents dephosphorylation of ADF/cofilin induced by ACh or forskolin, it 
suggests that slingshot is the specific phosphatase that regulates ADF/cofilin 
activity with ACh or forskolin stimulation. If not, another phosphatase might be 
involved or the inactivation of LIMK might be the cause of ADF/cofilin 
dephosphorylation. 
The research presented in this dissertation has unveiled the important 
role of ADF/cofilin in regulating actin polymerization and force generation in 
airway smooth muscle. ADF/cofilin is ubiquitously expressed across cell types 
and is likely to be present in all smooth muscle tissues. Thus, cofilin is likely to 
play a similar role in the regulation of contraction and relaxation in other smooth 
muscle tissues. Better understanding of the roles of ADF/cofilin activation in actin 
dynamics during smooth muscle tension development and its physiological 
functions may provide important insights into the physiological regulation of the 
properties of smooth muscle tissues and organs and may lead to novel targets 
for the development of new therapeutic agents.  
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Chapter IV 
Experimental Procedures 
 
Preparation of smooth muscle tissues and measurement of force. 
Mongrel dogs (20–25 kg) were anesthetized with pentobarbital sodium (30 mg/kg, 
i.v.) and quickly exsanguinated. Experiments were carried out in accordance with 
the guidelines of the Institutional Animal Care and Use Committee, Indiana 
University School of Medicine. A segment of the trachea was immediately 
removed and immersed in physiological saline solution (PSS) at 22 ºC 
(composition in mM: 110 NaCl, 3.4 KCl, 2.4 CaCl2, 0.8 MgSO4, 25.8 NaHCO3, 
1.2 KH2PO4, and 5.6 glucose). PSS was aerated with 95%O2–5%CO2 to 
maintain a pH of 7.4. Smooth muscle strips  (1 mm wide x 0.2–0.5 mm thick x 
15mm long) were dissected free of connective tissue and epithelium. Muscle 
strips were placed in PSS at 37 ºC in a 25 ml organ bath and attached to a force 
transducer for measurement of force. At the beginning of each experiment the 
optimal length for muscle contraction was determined by progressively increasing 
the length of the muscle until the active isometric force elicited by ACh reached a 
maximum (Lmax).  All tissues were then maintained at Lo for 30–60 min without 
stimulation. For experiments involving the introduction of plasmids encoding 
cofilin proteins, muscle strips were then subjected to the reversible 
permeabilization procedure described below. Two days were then allowed for 
expression of the recombinant proteins, at which time the active isometric force 
in response to ACh at Lo was determined again. For experiments involving the 
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introduction of cAMP elevating agents (Forskolin 10, 30, 100μM), muscle strips 
were incubated in PSS containing cAMP elevating agents for 30 minutes or 2 
hours. Then active isometric force in response to ACh at Lo was determined 
again. 
 Reagents. The following antibodies were used in these studies: mouse 
monoclonal anti–cofilin (BIOSOURCE), rabbit polyclonal anti–phospho–
ADF/cofilin at serine–3 antibody (113), and rabbit polyclonal anti–ADF/cofilin 
antibody (reacts with both ADF and cofilin) (152) provided by Dr. James 
Bamburg, Colorado State University; mouse monoclonal anti–actin (Clone AC–
40, Sigma); mouse monoclonal GAPDH (RDI, Concord, MA). Polyclonal myosin 
light chain antibody was custom–made by BABCO (Richmond, CA). pcDNA3.1 
vectors (human cytomegalovirus as promoter) encoding human wild type cofilin, 
inactive mutant cofilin S3E, human wild type slingshot1 and inactive phosphatase 
slingshot1 mutant C393S were provided by Dr. J. R. Bamburg (Colorado State 
University, Fort Collins). Cyclosporine A, deltamethrin and forskolin, isoproterenol 
(Sigma). 
Transfection of smooth muscle tissues with plasmids. Plasmids 
were introduced into tracheal smooth muscle strips by the method of reversible 
permeabilization as described previously (139; 173; 199). After initial equilibration 
and contraction to 10–5 M ACh to obtain maximal force, muscle strips were 
attached to metal mounts at Lo. The strips were incubated successively in each 
of the following solutions: Solution 1 (at 4 ºC for 120 min) containing (mM): 10 
EGTA, 5 Na2ATP, 120 KCl, 2 MgCl2, and 20 TES; solution 2 (at 4 ºC overnight) 
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containing (mM): 0.1 EGTA, 5 Na2ATP, 120 KCl, 2 MgCl2, 20 TES, and 10 μg/ml 
plasmids; Solution 3 (at 4 ºC for 30 min) containing (mM): 0.1 EGTA, 5 Na2ATP, 
120 KCl, 10 MgCl2, 20 TES; and solution 4 (at 22 ºC for 60 min) containing (mM): 
110 NaCl, 3.4 KCl, 0.8 MgSO4, 25.8 NaHCO3, 1.2 KH2PO4, and 5.6 dextrose. 
Solutions 1–3 were maintained at pH 7.1 and aerated with 100%O2. Solution 4 
was maintained at pH 7.4 and aerated with 95% O2, 5% CO2. After 30 min in 
Solution 4, CaCl2 was added gradually to reach a final concentration of 2.4 mM. 
The strips were then incubated in a CO2 incubator at 37 ºC for 2 days in serum–
free Dulbecco’s modified Eagle’s medium containing 5 mM Na2ATP, 100μg/ml 
penicillin, 100μg/ml streptomycin, and 10 μg/ml plasmids encoding human wild 
type cofilin, the inactive mutant cofilin S3E or slingshot phosphatase inactive 
C393S. 
Dissociation of airway smooth muscle cells from tissue strips. After 
completion of the force measurements, smooth muscle cells were enzymatically 
dissociated from tracheal muscle strips for the analysis of cellular protein 
distribution  by confocal microscopy (139). Tracheal muscle strips were minced 
and transferred to 5ml of dissociation solution (composition in mM: 130 NaCl, 5 
KCl, 1.0 CaCl2, 1.0 MgCl2, 10 HEPES, 0.25 EDTA, 10 D–glucose, and 10 taurine, 
pH 7) with collagenase (type I, 400 U/ml), papain (type IV, 30 U/ml), bovine 
serum albumin (1 mg/ml), and dithiothreitol (DTT; 1 mM). All enzymes were 
obtained from Sigma Co. (St. Louis, MO). The strips were then placed in a 37 oC 
shaking water bath for 20–30 min at 80 oscillations/min. The strips were then 
washed three times with a HEPES–buffered saline solution (composition in mM: 
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130 NaCl, 5 KCl, 1.0 CaCl2, 1.0 MgCl2, 20 HEPES, and 10 D–glucose, pH 7.4) 
and triturated with a pipette to liberate individual smooth muscle cells from the 
tissue. The cells were fixed for 10 min in 4% paraformaldehyde (vol/vol) in 
phosphate–buffered saline (composition in mM: 137 NaCl, 4.3 Na2HPO4, 1.4 
KH2PO4, and 2.7 KCl, pH 7.4). 
Confocal microscopy and image analysis. The efficiency of tissue 
transfection (Figure 23) was evaluated by determining the percentage of cells 
dissociated from plasmid–treated muscle tissues that expressed RFP–labeled 
proteins (see method described in Dissociation of airway smooth muscle cells 
from tissue strips). A Zeiss LSM 510 laser scanning confocal microscope was 
used to view RFP fluorescence in fixed smooth muscle cells freshly dissociated 
from muscle tissues treated with plasmids encoding RFP–tagged cofilin or 
untreated tissues. The RFP fluorescence was excited with a 543–nm argon laser 
light, and fluorescence emissions were collected at 565–615 nm with an Apo x40 
water–immersion lens objective (NA 1.2)  
Analysis of ADF/cofilin phosphorylation. ADF/cofilin isoforms and 
phosphorylation were analyzed by one–dimensional and by two–dimensional 
electrophoresis. Muscle tissues were rapidly frozen using liquid nitrogen–cooled 
tongs and pulverized using a mortar and pestle. Pulverized muscle tissues were 
mixed with extraction buffer containing the following: 20 mM Tris–HCl, pH 7.4, 
2% Triton X–100, 0.4% SDS, 2 mM EDTA, 2 mM EGTA, phosphatase inhibitors 
(2 mM sodium orthovanadate, 2 mM molybdate, and 2 mM sodium
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Figure 23. Expression of cofilin S3E in smooth muscle tissues. RFP 
fluorescence of live cells freshly dissociated from muscle strips treated with 
plasmids encoding the cofilin S3E or from muscle strips not treated with plasmids. 
Left: fluorescence images; right: phase–contrast images of the same fields. The 
efficiency of tissue transfection was evaluated by determining the percentage of 
cells dissociated from plasmid–treated and untreated muscle tissues that 
expressed RFP–labeled proteins. Most (80–90%) of the cells dissociated from 
the transfected tissues exhibited RFP fluorescence, whereas no fluorescence 
was observed in cells dissociated from untreated tissues. 
RFP
flourescence
Phase-
contrast
No 
plasmid
RFP-cofilin
S3E
 
 93
pyrophosphate, 50 mM sodium fluoride) and protease inhibitors (2 mM 
benzamidine, 0.5 mM aprotinin, and 1 mM phenylmethylsulfonyl fluoride).  
For one–dimensional electrophoresis, each sample was centrifuged for 
the collection of supernatant, and the supernatant was then boiled in sample 
buffer (1.5% dithiothreitol, 2% SDS, 80 mM Tris–HCl, pH 6.8, 10% glycerol, and 
0.01% bromphenol blue) for 5 min. Proteins were separated by 12% SDS–PAGE 
and transferred to nitrocellulose. To measure ADF/cofilin phosphorylation, the 
nitrocellulose membrane was simultaneously probed with antibodies to phospho–
Ser–3 ADF/cofilin and cofilin, followed by fluorophore–conjugated anti–rabbit and 
antimouse immunoglobulins. Fluorescence signals were detected and analyzed 
using an Odyssey fluorescence scanner (LI–COR Biosciences, Lincoln, NE). 
For two–dimensional PAGE, protein was precipitated from smooth 
muscle tissue protein extracts using a methanol/chloroform/ water mixture (190). 
The precipitated total smooth muscle protein was redissolved in ReadyPrep two–
dimensional sample buffer (Bio–Rad). Isoelectric focusing was performed in a 
PROTEAN IEF cell with 11–cm IPG strips pH 3–10 (Bio–Rad) according to the 
manufacturer’s instructions. The focused proteins were then separated by means 
of an 18% SDS–polyacrylamide gel and subsequently transferred to a 
nitrocellulose membrane (Bio–Rad). ADF and cofilin were detected using a 
polyclonal anti–ADF/cofilin antibody that reacts with both ADF and cofilin (152). 
The ratios of phosphorylated ADF and phosphorylated cofilin to total ADF and 
total cofilin and the amount of recombinant cofilin expression were analyzed by 
scanning densitometry. 
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Measurement of regulatory myosin light chain phosphorylation. 
Frozen muscle strips were immersed in dry ice precooled acetone containing 
10% w/v trichloroacetic acid and 10 mM dithiothreitol. Proteins were extracted in 
8 M urea, 20 mM Tris base, 22 mM glycine, and 10 mM dithiothreitol. 
Phosphorylated and unphosphorylated myosin lights chains (MLCs) were 
separated by urea–glycerol PAGE, transferred to nitrocellulose, and then 
probed using antibody to the 20–kDa myosin light chain (199; 200). Proteins 
were visualized by enhanced chemiluminescence (ECL). The ratio of 
phosphorylated to unphosphorylated MLC was determined by scanning 
densitometry. 
Analysis of F–actin and G–actin. The relative proportions of F–actin 
and G–actin in smooth muscle tissues were analyzed using a standard assay kit 
(Cytoskeleton, Denver, CO) as described previously (199; 200). Briefly, each of 
the tracheal smooth muscle strips was homogenized in 200 μl of F–actin 
stabilization buffer (50 mM PIPES, pH 6.9, 50 mM NaCl, 5 mM MgCl2, 5 mM 
EGTA, 5% glycerol, 0.1% Triton X–100, 0.1% Nonidet P–40, 0.1% Tween 20, 
0.1% β–mercaptoethanol, 0.001% antifoam, 1 mM ATP, 1 μg/ml pepstatin, 1 
μg/ml leupeptin, 10 μg/ml benzamidine, and 500 μg/ml tosyl arginine methyl 
ester). Supernatants of the protein extracts were collected after centrifugation at 
150,000 × g for 60 min at 37 oC. The pellets were resuspended in 200 μl of ice–
cold distilled water containing 10 μM cytochalasin D and then incubated on ice 
for 1 h to depolymerize F–actin. The resuspended pellets were gently mixed 
every 15 min. Four microliters of supernatant (G–actin) and pellet (F–actin) 
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fractions were subjected to immunoblot analysis. The ratios of F–actin to G–actin 
were determined using densitometry. 
Statistical analysis. Comparisons between the two groups were 
performed using paired Student’s t tests. Comparisons among multiple groups 
were performed using repeated measures analysis of variance. Values refer to 
the number of tissues used to obtain mean values. p < 0.05 was considered 
statistically significant. 
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